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ABSTRACT 
The MCM helicase plays a key role in DNA replication, as it unwinds the double helix, 
providing a single stranded template for the DNA polymerases. MCM genes are found 
both in Eukaryotes and Archaea. Eukaryotic genomes present at least 6 different MCM 
genes, which share significant sequence similarity. The six different polypeptides 
encoded by MCM genes assemble into a heteroexamer, characterized by a toroidal 
conformation. Each protein comprises 3 domains: the N-terminal domain binds DNA and 
is essential for hexamerization; the C-terminal domain folds as a winged-helix motif and 
may have a regulatory role; the central AAA+ domain is the catalytic core of the helicase 
that couples the ATP hydrolysis with DNA unwinding. Since the eukaryotic MCM 
complex is difficult to produce in large amounts, most of the available structural 
information derive from studies on the archaeal model. For eukaryotic MCM proteins no 
crystal structure has been determined yet, while low resolution reconstructions by 
electron microscopy are available only for S. cerevisiae and D. melanogaster complexes. 
The MCM proteins are present only in proliferating cells and are highly expressed in 
malignant cancer cells and pre-cancerous cells undergoing malignant transformation. 
Their expression has been compared with routinely used proliferation markers, showing 
that they are suitable candidates as biomarkers for cancer in clinical practice. Therefore, a 
detailed knowledge of their structure and function is a crucial pre-requisite for their 
potential role in cancer diagnosis and therapy. 
Based on bioinformatics analysis and structural information from archaeal MCM 
proteins, fragments corresponding to the AAA+ domains and N-terminal domains of the 
human MCM helicase were designed and cloned separately into different expression 
vectors. Various expression strategies were explored and constructs were tested for 
protein expression under a variety of conditions. 
AAA+ domains showed a severe problem of solubility: most of them precipitated during 
purification, aggregated or, in the best cases, precipitated after tag removal. The attempt 
to co-express or co-purify the subunits together didn’t improve the solubility of the 
proteins, also in presence of ATP analogues.  
The N-terminal domains were soluble and expressed at high levels. The co-purification of 
the six fragments led to the assembly of two different oligomeric states compatible with a 
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double and a single hexamer. Both oligomers fit the biological role of the protein, 
expected to be loaded onto the double stranded DNA as double hexamer and to unwind as 
single hexamer. DNA binding experiments were carried out by fluorescence polarization: 
both assemblies are able to bind different DNA substrates (single strand, double strand, 
fork) with micromolar dissociation constants, consistent with the DNA binding affinities 
reported for the archaeal MCM complex. A preliminary biophysical characterization 
performed with different techniques (thermal shift analysis, circular dichroism, 
multi-angle light scattering, small-angle X-ray scattering) revealed that the putative single 
hexamer is properly folded but quite unstable, as it showed the tendency to disassemble 
into smaller oligomers. In contrast, the putative double hexamer showed a higher 
stability, but still a degree of inhomogeneity which didn’t allow a structural study of its 
architecture. Nevertheless, the high yield of our purification protocol represents a 
promising starting point for further optimization, allowing crystallography and other 
structural studies. 
  
VIII 
 
AKNOWLEDGMENTS 
I would like to thank my supervisor, Dr. Silvia Onesti, for having given me the 
opportunity to work in her laboratory during the last three years, and Dr. Barbara 
Medagli, for having taught me all I know. 
I wish to express my gratitude to Dr. Shiva Jafarkhani for her previous work on the 
N-terminal domains, and to Dr. Alfredo De Biasio for his help with Circular Dichroism 
experiments and for the critical reading of this thesis.  
I also wish to thank Dr. Robert Rambo and all his group, for their help and assistance for 
MALS and SAXS experiments. I hope this was just the first step of a fruitful 
collaboration. 
I owe a massive THANK YOU to all the present and past members of the ELETTRA 
Biolab (too many to be listed here!) for their help, support and all the funny moments 
spent together: you all are fantastic people, both inside and outside the laboratory. 
 
I will never find proper words to express my gratitude to my Family and to 
Damiano: thank you for your love, patience, constant encouragement and 
for being my lifelines in the worst moments.  
This thesis is dedicated to you.  
 
  
IX 
 
 
 
  
 
  
X 
 
LIST OF FIGURES 
Figure 1.1: Organization of the replisome in E. coli ......................................... 4 
Figure 1.2: Schematic representation of stepwise helicase loading in 
S. cerevisiae .................................................................................... 
 
8 
Figure 1.3: Summary of stepwise activation of the replicative helicase in 
S. cerevisiae .................................................................................... 
 
10 
Figure 1.4: Proposed architecture of the eukaryotic replisome ........................ 13 
Figure 1.5: Primary structure of MCM proteins ............................................... 17 
Figure 1.6: Structure of N-terminal domain of MthMCM ................................ 18 
Figure 1.7: Crystal structures of the N-terminal domains from different 
archaeal organisms ......................................................................... 
 
19 
Figure 1.8: The active site of the MCM helicase .............................................. 20 
Figure 1.9: Overall arrangement of the hexameric Sso-PfuMCM .................... 22 
Figure 1.10: Structure of the Cdt1 binding domain of human Mcm6 ................. 23 
Figure 1.11: The apo-form of Drosophila MCM2-7 forms a gapped ring .......... 25 
Figure 1.12: Intermediates during the stepwise recruitment of MCM2-7 onto 
DNA ............................................................................................... 26 
Figure 1.13: EM side views of the MCM2-7 double hexamer ........................... 27 
Figure 1.14: EM reconstruction of the Drosophila CMG complex .................... 28 
Figure 1.15: Interdomain flexibility in CMG-DNA-ATPγS complex ................ 29 
Figure 1.16: Cartoon representation of the dimeric CMG complex ................... 30 
Figure 3.1: Schematic representation of polycistronic constructs .................... 41 
Figure 4.1: Human Mcm proteins ..................................................................... 58 
Figure 4.2: Cloning of AAA+ domains ............................................................ 59 
Figure 4.3: In-Fusion cloning ............................................................................ 60 
Figure 4.4: Small scale expression tests ............................................................ 62 
Figure 4.5: Purification strategy for AAA+ domains ....................................... 63 
Figure 4.6: Affinity chromatography for construct A2 ..................................... 63 
Figure 4.7: IEx chromatography for A2 ............................................................ 64 
Figure 4.8: Size exclusion chromatography for A2 .......................................... 65 
Figure 4.9: New cloning strategy for co-expression of Mcm subunits ............. 66 
Figure 4.10: Purification of co-expressed AAA+ domains ................................ 68 
Figure 4.11: Example of individually purified N-terminal domains .................. 70 
XI 
 
Figure 4.12: Co-purification of N-terminal domains .......................................... 71 
Figure 4.13: Size exclusion chromatography ...................................................... 73 
Figure 4.14: Finale size exclusion chromatography ........................................... 74 
Figure 4.15: Principles of Thermofluor .............................................................. 76 
Figure 4.16: Panel of conditions for Thermofluor .............................................. 77 
Figure 4.17: Melting curves ................................................................................ 78 
Figure 4.18: Summary of Thermofluor results ................................................... 80-81 
Figure 4.19: CD spectra of single and double hexamer ...................................... 83 
Figure 4.20: Comparison between theoretical and experimental CD curves of 
the single hexamer .......................................................................... 84 
Figure 4.21: Fluorescence polarization assay ..................................................... 85 
Figure 4.22: Analysis of fluorescence polarization data obtained for the single 
hexamer .......................................................................................... 86 
Figure 4.23: EMSA of single hexamer with ssDNA .......................................... 88 
Figure 4.24: Analysis of fluorescence polarization data obtained for the double 
hexamer .......................................................................................... 89 
Figure 4.25: Mass distribution across the elution peak of double and single 
hexamer .......................................................................................... 91 
Figure 4.26: Fitting of experimental scattering curve with different MCM 
models ............................................................................................. 93-94 
Figure 4.27: Double hexamer crystallization trials ............................................. 96 
Figure A.1: Sequence alignment of MCM homologues .................................... 98 
 
 
  
XII 
 
LIST OF TABLES 
Table 3.1: List of primers for RF cloning ................................................................ 39 
Table 3.2: List of constructs for expression of the AAA+ domains ....................... 42 
Table 3.3: Summary of conditions tested for the expression of the AAA+ 
domains ................................................................................................... 44 
Table 3.4: List of constructs for the expression of N-terminal domains ................. 49 
Table 3.5: List of oligonucleotides used for DNA binding assay ............................ 52 
Table 3.6: Models of MCM proteins ....................................................................... 55 
Table 3.7: Summary of crystallization trials in 96 well sparse matrix .................... 56 
Table 4.1: Summary of constructs of AAA+ domains ............................................ 61 
Table 4.2: Summary of purification results for independently expressed AAA+ 
domains ................................................................................................... 65 
Table 4.3: List of expressed constructs of N-terminal domains .............................. 70 
Table 4.4: Secondary structure analysis for the single hexamer ..............................  83 
Table 4.5: Binding of single hexamer to different DNA probes .............................. 87 
Table 4.6: Binding of double hexamer to different DNA probes ............................ 90 
 
  
XIII 
 
  
XIV 
 
LIST OF ABBREVIATIONS 
AAA+: ATPases Associated with 
various cellular Activities 
ACL: Allosteric Communication Loop 
ADP: Adenosine Diphosphate 
AEBSF: 4-(2-Aminoethyl) 
benzenesulfonyl fluoride hydrochloride 
Alch: Alcohol dehydrogenase 
Ald: Aldolase 
AND1/Cft4: Acidic Nucleoplasmic 
DNA-binding protein 1/Chromosome 
transmission fidelity 4 
APC/C: Anaphase-Promoting 
Complex/Cyclosome  
APS: Ammonium Persulfate 
ASCE: Additional Strand Catalytic E 
ATP: Adenosine Triphosphate 
BisTris: Bis-(2-hydroxy-ethyl)-amino-
tris(hydroxymethyl)-methane 
Bmax: polarization at saturation 
bp: base pairs 
CD: Circular Dichroism 
Cdc45: Cell division cycle 45 
Cdc48: Cell division cycle 48 
Cdc6: Cell division cycle 6 
CDK: Cyclin Dependent Kinase 
Cdt1: Chromatin licensing and DNA 
replication factor 1 
CHES: N-Cyclohexyl-2-
aminoethanesulfonic acid 
CMG: Cdc45-MCM2-7-GINS 
Con: Conalbumin 
CV: Column Volume 
Dbf4: Dumbbell former 4  
DDK: Dbf4-Dependent Cdc7 Kinase 
DH: Double Hexamer 
Dia2: Digs into agar 2 
DMSO: Dimethyl Sulfoxide 
DNA: Deoxyribonucleic Acid 
Dpb11: DNA polymerase B (II) 
dsDNA: double stranded DNA  
DTT: Dithiothreitol 
EDTA: Ethylenediaminetetraacetic Acid 
ELU: Elution 
EM: Electron Microscopy 
EMSA: Electrophoretic Mobility Shift 
Assay 
EXT: External β-hairpin 
Fer: Ferritin 
FF: Fast Flow 
FPLC: Fast Protein Liquid 
Chromatography 
FT: Flow-Trough 
GINS: Go-Ichi-Nii-San (5-1-2-3 in 
Japanese) 
h: Hill coefficient 
H2I: Helix 2 Insert 
I 
 
Hepes: 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
His: Histidine 
HP: High-Performance 
HPLC: High-Performance Liquid 
Cromatography  
HTH: Helix-Turn-Helix 
IEx: Ion Exchange  
IGEPAL: 
Octylphenoxypolyethoxyethanol 
IPTG: Isopropyl β-D-1-
thiogalactopyranoside 
Kav: partition coefficient 
Kd: apparent binding constant 
LB: Luria Broth 
MALDI-TOF: Matrix Assisted Laser 
Desorption Ionization-Time-of-Flight 
MALS: Multi-Angle Light Scattering 
MBP: Maltose Binding Protein 
Mcm10 
Mcm2: Mini-Chromosome Maintenance 
protein 2 
MCM2-7: Mini-Chromosome 
Maintenance protein complex 2-7 
Mcm3: Mini-Chromosome Maintenance 
protein 3 
Mcm4: Mini-Chromosome Maintenance 
protein 4 
Mcm5: Mini-Chromosome Maintenance 
protein 5 
Mcm6: Mini-Chromosome Maintenance 
protein 6 
Mcm7: Mini-Chromosome Maintenance 
protein 7 
MES: 2-(N-morpholino)ethanesulfonic 
acid 
MME: Monomethyl Ether 
MOPS: 3-(N-morpholino)propansulfonic 
acid 
Mth: Methanothermobacter 
thermautotrophicus 
MW: Molecular Weight 
MWCO: Molecular Weight Cut-Off 
NBH: N-terminal β-Hairpin 
Ni-NTA: Nickel-Nitrilotriacetic acid 
NPS: Nitrogen-Phosporus-Sulfur 
NSD: Non-Structured Domains 
nt: nucleotides  
OCCM: ORC-Cdc6-Cdt1-MCM2-7 
OCM: ORC-Cdc6-MCM2-7 
OCMM: ORC-Cdc6-MCM2-7-MCM2-7 
OD: Optical Density 
ORB: Origin Recognition Boxes 
ORC: Origin Recognition Complex 
Orc1: Origin recognition complex, 
protein 1 
Orc2: Origin recognition complex, 
protein 2 
Orc3: Origin recognition complex, 
protein 3 
II 
 
Orc4: Origin recognition complex, 
protein 4 
Orc5: Origin recognition complex, 
protein 5 
Orc6: Origin recognition complex, 
protein 6 
PBS: Phosphate-Buffered Saline 
PCNA: Proliferating Cell Nuclear 
Antigen 
PCR: Polymerase Chain Reaction 
PDVF: Polyvinylidene Fluoride 
PEG: Polyethylene Glycol 
Pfu: Pyrococcus furiosus 
pI: Isoelectric point 
PMSF: Phenylmethanesulfonylfluoride 
Pol III: DNA Polymerase III 
Pol α: DNA Polymerase α 
Pol δ: DNA Polymerase δ 
Pol ε: DNA Polymerase ε 
PolB: DNA Polymerase B 
PolD: DNA Polymerase D 
pre-IC: pre-Initiation Complex 
pre-RC: pre-Replication Complex 
PriL: Primase Large subunit 
PriS: Primase Small subunit 
PS1βH: Pre-Sensor 1 β-Hairpin 
R2: coefficient of determination 
RBS: Ribosome Binding Site  
RecA: Recombinase A 
RF: Arginine Finger 
RF: Restriction Free 
RFC: Replication Factor C 
Rg: Radius of gyration 
RIPL: arginine/isoleucine/proline/leucine 
RNA: Ribonucleic Acid 
RP: arginine/proline 
RPA: Replication Protein A 
sA: subdomain A 
SAXS: Small Angle X-ray Scattering 
sB: subdomain B 
sC: subdomain C 
SCF: Skp1-Cullin-F-box 
SDS-PAGE: Sodium Dodecyl Sulphate - 
PolyAcrylamide Gel Electrophoresis 
SEC: Size Exclusion Chromatography  
SH: Single Hexamer 
SI: Sensor 1 
SII: Sensor 2 
Sld2: Synthetically lethal with Dpb11-1 
protein 2 
Sld3: Synthetically lethal with Dpb11-1 
protein 3 
Sld5 : Synthetically lethal with Dpb11-1 
protein 5 
Sld7: Synthetically lethal with Dpb11-1 
protein 7 
SOL: Soluble fraction 
III 
 
SOM: Self Organizing Map 
SSB: Single Strand Binding protein 
ssDNA: single stranded DNA 
Sso: Sulfolobus solfataricus 
SUMO: Small Ubiquitin-like Modifier 
Tac: Thermoplasma acidophilum 
TB: Terrific Broth 
TBE: Tris/Borate/EDTA 
TE: Total Extract 
TEMED: N,N,N',N'-
Tetramethylethylenediamine 
Thr: Thyroglobulin 
Tm: melting Temperature 
TopBP1: Topoisomerase Binding 
Protein 1 
TPBS: Tween-Phosphate-Buffered 
Saline 
Tris: Tris(hydroxymethyl)aminomethane 
tRNA: transfer RNA 
Ulp1: Ubiquitin-like-specific protease 1  
UV: Ultra Violet 
V0: void volume 
Ve: elution volume 
Vt: bed volume 
W1: Wash 1 
W2: Wash 2 
WA: Walker A 
WB: Walker B 
WH: Winged Helix 
WhiP: Winged helix initiator Protein 
βME: β-Mercaptoethanol 
 
  
1 
 
1 INTRODUCTION 
1.1 Role of MCM helicases in DNA replication 
The accurate copying of the genetic information stored in the DNA double helix is 
essential for the inheritance of the traits which characterize cells and organisms. In 
complex organisms the duplication process not only needs to be highly accurate but it 
also requires to be coordinated with inheritance of chromatin, developmental patterns of 
tissues and cell division. The tight control of DNA replication is one of the most complex 
processes in the cell which has to ensure that each DNA molecule is copied only once per 
cell cycle and that disease-causing mutations are avoided.  
Helicases are enzymes that physically displace the two strands of the double helix to 
provide a single stranded template for the DNA polymerase and are therefore crucial in 
DNA replication in all domains of life. Thus, it is not surprising that they are subjected to 
several control mechanisms. The replicative helicase is typically a six-subunit complex 
which uses ATP hydrolysis to translocate along the DNA while unwinding it. Bacterial 
helicases are homohexamers which show a RecA-like architecture (Enemark and Joshua-
Tor, 2008) and travel along the lagging strand with a 5’3’ directionality. In Eukarya, 
replicative helicase role is played by a complex formed by six different subunits, known 
as MCM2-7 (minichromosome maintenance 2-7), which is characterised by a AAA+ fold 
and tracks along the leading strand on a 3’5’ direction (Medagli and Onesti, 2013).  
The Mcm genes were first discovered in Saccharomyces cerevisiae as mutants of Mcm2, 3 
and 5 that caused defects in plasmid segregation (Maine et al., 1984). They were found to 
be essential for viability and necessary for both initiation of DNA replication and DNA 
elongation (Bochman and Schwacha, 2009). The Mcm2-7 genes share high sequence 
similarity with one another and with their archaeal counterparts.  
The aim of this chapter is to provide a brief overview about DNA replication in the three 
domains of life (Bacteria, Archaea and Eukarya), to highlight differences and similarities, 
with a particular focus on the role of MCM helicases in the different steps of this process. 
Their involvement in regulation mechanisms and interactions with other replication 
factors will be also addressed.    
1.1.1 Key steps in replication are invariant among species 
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In the cell, the replication process starts at a specific DNA region called the “origin” 
which need to be at first recognised and activated by initiator proteins. Origins are 
activated by DNA-binding proteins that are typically multimeric machines belonging to 
the AAA+ family. Their purpose is to load two helicases onto the DNA to create two 
replication forks that will move in opposite directions. Other replication factors are 
required to deliver the helicase at the origin and to load it onto the DNA. The helicase 
loading and activation are key regulation points of replication, but the mechanisms that 
control these processes can significantly vary among species.  
After activation, the helicase starts its melting activity and this is necessary to allow the 
synthesis of primers. Priming is performed by a DNA-dependent RNA polymerase and, 
as DNA polymerase is not able to autonomously initiate a new chain, it is a necessary 
prerequisite for elongation. The first primer is synthesised on the leading strand. 
Subsequent priming events also occur on the lagging strand to form the Okazaki 
fragments.    
Primer elongation on both strands is performed simultaneously by a multiprotein complex 
called “replisome”, formed by the following key components: helicase, primase, 
DNA-polymerase, sliding clamps, a clamp loader and single strand binding proteins. 
Other factors, varying among species, can be present to activate, stabilise and control the 
replisome.  
1.1.2 DNA replication in Bacteria 
The replication machinery in Bacteria is assembled at a single origin, characterised by the 
repetition of a specific sequence (DnaA boxes) that is recognised by and binds to multiple 
copies of the DNA-binding protein DnaA. The availability of the origin for replication 
depends on its methylation state, which is ultimately related to the growth condition of 
the cell and, in Escherichia coli, is tightly regulated by SeqA that can sequester the origin 
and prevent access to DnaA. Multiple copies of DnaA assemble into a filament and 
hydrolyse ATP to unwind the AT-reach region of the origin, creating a single stranded 
“bubble”.  
DnaC, or the helicase loader, is a AAA+ protein that in its ATP-bound form interacts with  
an inactive form of the bacterial DnaB helicase. It cooperates with DnaA to deliver and 
load DnaB on the single strand DNA at the origin. Subsequent ATP hydrolysis causes its 
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release and the helicase activation (Kaguni, 2011). DnaB helicase transiently binds E. coli 
primase DnaG, which synthetises an RNA primer of ~12 nucleotides (nt). 
The bacterial replisome is assembled by the clamp loader, which binds three copies of 
DNA polymerase III (Pol III) and the helicase. As the primase synthetises a new primer 
on the lagging strand, the clamp loader loads a new circular β-clamp onto the 
primer/template. The Single Stranded Binding Protein (SSB) binds the single strand, 
induces the primase/polymerase switch and enables the clamp loader to displace the 
primase from the priming site. It also facilitates DNA elongation by Pol III.  
The bacterial replisome is highly processive, and in E. coli it can synthesize ~86 kb on the 
leading strand without dissociating from its template (Georgescu et al., 2010). However 
the high processivity requires the frequent detachment of the polymerase from the lagging 
strand. To overcome this problem, the three Pol III copies generate numerous short 
Okazaki fragments, detach from the template and continuously reassociate with a new 
clamp on the next priming site (Hedglin et al., 2013). 
As the initiation of replication occurs, the replisome stays in place while the newly 
synthesised origins are moved to predetermined locations. As the two forks proceeds 
along the DNA, they eventually meet at the termination site. Thanks to the spatial 
separation of origin and termination sites, under optimal growth conditions bacteria can 
possibly initiate a new replication cycle before finishing the previous one. Multiple 
chromosomes eventually segregates in different cells.       
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1.1.3 DNA replication in Eukarya 
The much higher complexity and length of the eukaryotic genomes require a more 
complex regulatory system to ensure genomic stability.  
First of all, Eukaryotes have to deal with multiple origins that are necessary to replicate 
large genomes within a reasonable amount of time. It has been established, for example, 
that the duplication of the largest human chromosome (chromosome 1) from a single 
origin would require 50 days instead of the typical 8 hours for DNA replication during the 
S phase of the cell cycle (O’Donnell et al., 2013). The fastest way to replicate multiple 
chromosomes would be the activation of all origins at the same time, but this event is 
very rare and happens only in first stages of embryonal development, as shown for 
Xenopus and Drosophyla (O’Donnell et al., 2013). Typically, cells use only a subset of 
origins. If an origin is used or not is a stochastic event which depends on the chromatin 
context and, in multicellular organisms, on the developmental pattern in which the cell is 
Figure 1.1: Organization of the replisome in E. coli (adapted from O’Donnell et al., 2013). 
The helicase (DnaB) encircles the lagging strand. Three molecules of Pol III are attached to one 
clamp loader. The clamp loader binds the helicase and repeatedly assembles β-clamps onto 
primed sites formed by the primase.     
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involved. Origins are organised in different clusters which are activated at specific times 
during the S phase, with a pattern that is typical of each cell type. 
Secondarily, and unlike Bacteria, Eukaryotes cannot perform re-replication. The 
re-initiation at some origins would lead to a different number of copies for different 
chromosomal regions, which would eventually cause problems during chromosomal 
segregation. Therefore tight regulatory mechanisms have been developed to ensure that 
each origin is activated once, and only once, in each cell cycle. In Eukaryotes, this high 
level of control is obtained by separating the initiation events in different phases of the 
cell cycle and imposing multiple regulatory processes (Diffley, 2011). Briefly, origin 
activation is achieved in two well distinguished steps, called “licensing” and “firing”. 
Origin licencing is achieved during the G1 phase when an inactive form of the replicative 
helicase is loaded on the double-stranded DNA (dsDNA) through the assembly of a 
pre-replicative complex (pre-RC). The subsequent activation of the helicase defines the 
origin firing. This event occurs during the S phase by means of specific kinases which 
drive the association of GINS and Cdc45 to MCM2-7, converting the complex in an 
active helicase, the Cdc45-MCM-GINS (CMG complex) (Ilves et al., 2010). The 
unwinding of DNA by the CMG triggers the priming activity and the assembly of a 
complete replisome, by subsequent association of polymerases (Pol ε for the leading 
strand and Pol δ for the lagging strand) and other partners involved in the replication 
process. During the S phase, licensing factors that are necessary for loading MCM2-7 are 
eliminated (either by protein degradation or nuclear exclusion), preventing the origin 
from a new licencing event and avoiding re-replication. 
The next section will describe the chain of events leading to initiation, elongation and 
termination of DNA replication in S. cerevisiae. Regulation of this events will be further 
discussed in section 1.1.3.4.        
1.1.3.1 Origin recognition and recruitment of MCM2-7 
With the exception of S. cerevisiae, a typical eukaryotic origin is not characterised by a 
specific DNA sequence, but it is mostly defined by chromatin organization, with many 
origins corresponding to regions of DNA with high levels of transcriptional activity or 
other features that allow access to origin-binding proteins (Masai et al., 2010). 
Nevertheless, many human cell origins occur in sequences that are evolutionarily 
conserved among mammals, suggesting that they are not arbitrary (Cadoret et al., 2008). 
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Consistently, the Origin Recognition Complex (ORC) of vertebrates shows no sequence 
specificity in vitro (Remus et al., 2004) but is localized to specific sites along the 
chromosomes, suggesting the existence of other factors that trigger its localization 
(Kawakami and Katayama, 2010).   
ORC is an heterohexamer: five of the six subunits (Orc1, 2, 3, 4 and 5) show sequence 
similarity with AAA+ proteins, but only two of them (Orc1 and 5) are known to bind 
ATP (Klemm et al., 1997), while Orc6 lacks this similarity and is in general poorly 
conserved among eukaryotes. ORC is known to bind the origin in an ATP-dependent 
manner in S. cerevisiae (Bell and Stillman, 1992).   
As the cell enters in the G1 phase, ORC recruits MCM2-7 at the origin with the help of 
other two licensing factors: Cdc6 and Cdt1. The current consensus view is that ORC 
bound to the origin interacts with Cdc6-ATP bound state and subsequently this complex 
recruits Cdt1- MCM2-7. 
Cdc6 is a AAA+ protein of the same clade of the ORC subunits. The complex ORC-Cdc6 
has been structurally characterised (Speck et al., 2005; Sun et al., 2012) and ORC was 
shown to stimulate ATP hydrolysis by Cdc6 after origin binding (Randell et al., 2006). 
Cdt1 and MCM2-7 are imported to the nucleus as a complex and their assembly is 
necessary for their recruitment to the origin (Tanaka and Diffley, 2002; Takara and Bell, 
2011). Cdt1 is poorly conserved but always shows a winged-helix domain at its 
carboxy-terminal part, that mediates its binding to MCM2-7 (Teer and Dutta, 2008; 
Takara and Bell, 2011). Cdt1 mutants lacking this region were shown to prevent helicase 
loading (Takara and Bell, 2011).  
Cdt1-MCM2-7 recruitment is probably mediated by the interaction of the C-terminal 
domain of Mcm3 and Cdc6, as suggested by protein-protein interaction studies and by 
electron microscopy (EM) models, showing the C-terminus of Mcm3 oriented toward 
ORC-Cdc6 (Sun et al., 2013). EM studies also demonstrated that ORC acquires  a 
different structure upon Cdc6 binding (Sun et al., 2012) and would explain its inability to 
bind either Cdt1 or MCM2-7 in the absence of Cdc6 (Takara and Bell, 2011). As a result 
of the stepwise recruitment of Cdc6 and Cdt1-MCM2-7, the OCCM complex is formed 
(ORC-Cdc6-Cdt1-MCM).  
1.1.3.2 Loading of the MCM2-7 double hexamer 
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Different models have been proposed for the loading of the MCM2-7 double hexamer. 
Initial evidences suggested that both rings were loaded in a concerted way, but more 
recently a stepwise model has been proposed, supported by biochemical experiments and 
EM maps (Figure 1.2). 
The assembly of the OCCM complex induces the ATP hydrolysis mediated by Orc1 and 
Cdc6, leading to the release of Cdt1 to form the OCM complex (ORC-Cdc6-MCM2-7), 
which is competent for the recruitment of a second MCM2-7 ring. In vitro and in vivo 
experiments showed that ATP binding and hydrolysis events of the MCM complex 
influence the stability of the MCM ring itself as well as the formation of the double 
hexamer at the origin (Coster et al., 2014). A tight interaction between the N-terminal 
domains of the two MCM complexes is also required for the proper loading of the double 
hexamer (Evrin et al., 2014). The structural remodelling of the proteins involved in the 
loading process started to be described just recently (Sun et al., 2013, 2014). The spiral 
form acquired by ORC-Cdc6 upon formation of the OCCM complex may promote the 
opening of the MCM ring necessary for its loading. It still unclear when and how the 
recruitment of the second MCM2-7 occurs, but the available information indicate that it is 
a slow process that still requires the presence of Cdt1 and Cdc6 at the origin. 
The role of the licensing factors ORC, Cdc6 and Cdt1 after loading is unclear. In vitro 
studies show that they are released from the origin after helicase loading (Randell et al., 
2006; Tsakraklides and Bell, 2010), and that the double hexameric MCM2-7 no longer 
needs them to associate with origin DNA (Donovan et al., 1997; Randell et al., 2006). In 
contrast to these findings, the inactivation of ORC or Cdc6 after MCM2-7 loading in 
S. cerevisiae causes its detachment, suggesting they are required in vivo to maintain the 
helicase associated with the origin (Aparicio et al., 1997; Chen et al., 2007; Semple et al., 
2006). In any case, upon entry into S phase the association of MCM2-7 with the origin 
becomes tight (unless initiation has occurred) and does not rely any more on loading 
proteins, as both Cdc6 and Cdt1 are eliminated by degradation.   
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1.1.3.3 Origin firing: activation of unwinding and priming activities 
The loaded MCM2-7 encircles the dsDNA as double hexamer and remains inactive 
during the rest of the G1 phase. Nevertheless, the active helicase at the replication fork is 
known to act as a single hexamer on the single stranded DNA (ssDNA) (Fu et al., 2011; 
Yardimci et al., 2010). This indicates that, at a certain stage during replication initiation, 
two major changes need to occur. First of all, the two hexamers have to dissociate. 
Figure 1.2: Schematic representation of stepwise helicase loading in S. cerevisiae (adapted 
from Riera et al., 2014). (1) ORC is bound to DNA. (2) Cdc6 associates to ORC. (3) ORC-Cdc6 
recruits Cdt1-MCM2-7. (4) Cdt1 dissociates after ATP hydrolysis by Orc1 and Cdc6. (5) The 
OCM complex recruits the second MCM2-7  in a slower reaction, which may involve a second 
ORC-Cdc6 complex. (6) Final product of the loading process is the MCM2-7 double hexamer on 
the origin.    
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Secondarily, both hexamers need to expel the lagging strand template before DNA 
unwinding.   
The activation of the helicase requires the association of two activating proteins (GINS 
and Cdc45) to MCM2-7 (Ilves et al., 2010), through the assembly of a pre-initiation 
complex (pre-IC). The pre-IC is defined as a complex formed just before the initiation of 
DNA replication (Zou and Stillman, 1998). Its assembly is necessary to activate the 
helicase and consists  in a two-step process that occurs during the passage through the S 
phase, triggered by two kinases: S phase CDK (S-CDK) and Dbf4-dependent Cdc7 kinase 
(DDK) (Figure 1.3). 
In budding yeast, Cdc45 first associates with the pre-RC in a DDK-dependent manner 
(Heller et al., 2011; Tanaka et al., 2011). Accumulating evidence, recently reviewed by 
Tanaka and Araki (2013), strongly suggests that DDK triggers this event by 
phosphorylating the MCM2-7 complex. It is also known that the loading of Cdc45 
requires its previous assembly with Sld3 and Sld7. How the phosphorylation of MCM2-7 
promotes the interaction between this complex and Sld3–Sld7–Cdc45 remains obscure. 
In the second step, GINS associates with the origin in a CDK dependent manner (Heller 
et al., 2011; Masumoto et al., 2002; Muramatsu et al., 2010; Tak et al., 2006; Tanaka et 
al., 2007; Zegerman and Diffley, 2006). The recruitment of GINS requires the assembly 
of a pre-loading complex (pre-LC), formed by GINS, Sld2, Dpb11 and Pol ε. 
Phosphorylation of Sld2 by CDK triggers the association of the pre-LC, that is 
subsequently loaded via CDK phosphorylation of Sld3, that acts as a bridge between 
Dpb11 and phosphorylated Sld2 (Tanaka and Araki, 2013). As the origin fires, Sld3, 
Sld7, Dpb11, and Sld2 do not move with the replication forks. In this step also Mcm10 is 
loaded at the origin, and its presence is necessary for the formation of an active helicase. 
After pre-LC association of the replicative helicase, the CMG complex is assembled. 
However it is still unclear how the separation of the double hexamer, the DNA melting 
and the ring opening for the extrusion of the lagging strand occur. Only when this 
transition is complete DNA can be unwound and provide a template for primase activity 
to initiate replication. 
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Figure 1.3: Summary of stepwise activation of the replicative helicase in S. cerevisiae 
(adapted from Tanaka and Araki, 2013). (1) DDK phosphorylation of MCM2-7 triggers the 
association of Cdc45 through the formation of a complex with Sld3-Sld7. (2) CDK phosphorylates 
Sld2, which assembles in the Pre-LC with Dpb11, Polε and GINS; the Pre-LC mediates the 
association of GINS to MCM2-7, via CDK phosphorylation of Sld3. (3) Association of MCM10 
and other replication factors (primase, polymerase, etc.) leads to the establishment of two 
replication forks, moving in opposite directions. Sld2, Sld3, Sld7 and Dpb11 do not move with the 
replisome. 
 
Unlike the core of the replication machinery, that is well conserved, the regulatory 
components that promote the initiation of DNA replication have diverged during 
evolution. In higher Eukaryotes, TopBP1, RecQ4 and Treslin/Ticrr were identified as 
functional homologs of Dpb11, Sld2, and Sld3, respectively. All of them show limited 
sequence similarity to their yeast counterparts and are much larger in size (Garcia et al., 
2005; Hashimoto and Takisawa, 2003; Van Hatten et al., 2002; Kumagai et al., 2010; 
Mäkiniemi et al., 2001; Matsuno et al., 2006; Sangrithi et al., 2005; Sansam et al., 2010). 
Although these proteins are required for the initiation of DNA replication, the 
requirement for, and order of, association with chromatin vary slightly among them. 
After origin unwinding, the ssDNA-binding protein RPA (Replication Protein A) 
associates with origin DNA. Two DNA polymerase α (Pol α)/Primase, for the leading and 
the lagging strand, can be recruited by interacting with AND1/Cft4, which also associates 
with the CMG via Sld5 (Simon et al., 2014). Pol α/primase complex synthetises an RNA 
of ~12 nt and extends it with ~25 nt of DNA. These hybrid RNA/DNA primers are then 
elongated by Pol ε and Pol δ, on the leading and lagging strands respectively (Burgers, 
2008).  
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1.1.3.4 General regulation of the initiation phase 
The two steps of initiation (i.e. origin licensing and firing) are isolated from each other in 
different stages of the cell cycle. No origin firing can be allowed in G1 phase while 
pre-RC complex is assembled. Conversely, no origin licensing can be permitted during S 
phase while origin activation is triggered. This ensures that multiple replication forks do 
not initiate from the same origin, thus preventing re-replication. The insulation of these 
two steps is achieved through a complex series of different mechanisms (phosphorylation, 
degradation, nuclear exclusion), reviewed by Siddiqui et al. (2013), that regulate the 
activation and inhibition of the different licensing and firing factors. The crosstalk among 
these mechanisms is mainly obtained by concerted action of two enzyme complexes: the 
CDK and the anaphase-promoting complex/cyclosome (APC/C). 
Eukaryotes express different cyclin proteins during different stages of the cell cycle. The 
association of the cyclin to CDK determines the substrate specificity of the kinase, 
resulting in the phosphorylation of different targets during the different stages: the G1-
phase cyclin–CDKs (G1-CDKs) phosphorylate proteins to promote S-phase entry, while 
S-phase cyclin–CDKs (S-CDKs) are required to activate DNA replication. 
The APC/C is a multisubunit ubiquitin ligase that polyubiquitinates proteins that are 
subsequently degraded by the proteasome. CDK and APC/C enzymes regulate each other, 
and their peak activity times are mutually exclusive in the cell cycle.  
Origin licensing occurs exclusively during late mitosis and G1 phase, when APC/C 
activity is high and S-CDK activity is low. Premature initiation of licensed origins is 
therefore prevented because the targets of S-CDK, Sld2 and Sld3, are not phosphorylated. 
Moreover, protein levels of pre-LC components Dpb11 and Sld2 are low.  
All origins must be licensed before cells can enter the S phase, because high CDK activity 
in the rest of the cell cycle would prevent any further licensing. The mechanisms of 
inhibition of the helicase loading outside the G1 phase are diverse and vary among 
organisms. In budding yeast, CDK phosphorylates Cdc6, leading to its degradation 
(Drury et al., 2000). Other inhibitory mechanisms are the nuclear export of MCM2-7 
(Labib et al., 1999; Nguyen et al., 2000) and the inhibition of Cdt1/MCM2–7 binding to 
ORC (Chen and Bell, 2011). In metazoan organisms, the primary target is Cdt1, that is 
degraded in a CDK dependent manner during S phase (Li et al., 2003; Liu et al., 2004) 
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and inhibited by Geminin binding outside of G1 phase (McGarry and Kirschner, 1998; 
Wohlschlegel, 2000). In many metazoans, CDK activity also inhibits ORC DNA binding 
during G2/M phase (reviewed in DePamphilis, 2005). 
In addition, the activity of DDK, which trigger the association of Sld3, Sld7, and Cdc45 
with the pre-RC, is strictly regulated by Dbf4, whose level increases at G1/S boundary, is 
kept high in the S phase, and decreases from late M phase (Cheng et al., 1999; Ferreira et 
al., 2000; Oshiro et al., 1999).  
1.1.3.5 The eukaryotic replisome 
The eukaryotic replisome shows many similarities, but also many differences, with its the 
bacterial counterpart. As described above, the eukaryotic replicative helicase requires 
additional factors to display its unwinding activity, and encircles the leading strand, not 
the lagging strand. Also, the eukaryotic replisome contains two different polymerases that 
function separately for the leading and lagging strands, Pol ε and Pol δ, respectively, in 
addition to Pol α/primase, which starts each Okazaki fragment. The lagging strand is 
coated by RPA, a heterotrimeric complex analogous to the bacterial SSB tetramer that 
also mediates the primase/polymerase switch. Both Pol ε and Pol δ function with the ring-
shaped proliferating cell nuclear antigen (PCNA) clamp that shows a structure similar to 
the E. coli β-clamp. PCNA is assembled on DNA by the pentameric Replication Factor C 
(RFC) clamp loader, composed of subunits with sequence homology and structure similar 
to the bacterial clamp loader (Garg and Burgers, 2005). Unlike bacteria, RFC does not 
appear to contact the polymerases or the helicase, and the connections among replisome 
components remain unclear.  
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1.1.3.6 What happens when replication terminates 
How the replisome is dismantled at the end of the replication process is currently debated 
and the fate of the helicase, in particular, remained obscure for a long time. Recent 
publications by Maric et al., (2014) and Priego Moreno et al., (2014) started to shed light 
on this topic. 
The disassembly of the replicative DNA helicase was demonstrated to be an active 
process, mediated by a member of the Skp1-Cullin-F-box (SCF) family of ubiquitin 
ligases. SCF polyubiquitylates a specific MCM2-7 subunit (Mcm7), triggering the 
disassembly and release of the CMG complex from DNA upon termination of synthesis. 
In budding yeast, the F-box protein which controls the substrate specificity of SFC is 
Dia2. The elimination of SCF/Dia2 results in the retention of the CMG complex on DNA 
Figure 1.4: Proposed architecture of the eukaryotic replisome (adapted from O’Donnell et 
al., 2013). The CMG complex encircles the leading strand. The RFC clamp loader repeatedly 
loads PCNA clamps on lagging-strand primers synthesised by Polα-primase. The clamp loader 
may not form stable attachments to the replisome. The leading and the lagging strand are 
replicated by Polε and Polδ respectively. Polε is stabilised on DNA by Mrc1. MCM10 and Cft4 
contact Polα-primase.  
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even after cells enter the next G1 phase, and the inhibition of Mcm7 ubiquitylation causes 
replication defects consistent with inhibition of replication termination. 
In addition, Cdc48, an ATPase that forms a hexameric ring, was also demonstrated to be 
involved in the disassembly of the helicase. Cdc48 specifically associates with 
ubiquitylated CMG complexes, and its elimination also results in the retention of the 
CMG complex on the chromatin. 
Currently, Mcm7 is speculated to be removed from the CMG by ATP-dependent 
translocation through the Cdc48 hexameric ring, therefore opening the MCM2-7 ring and 
providing an exit for DNA (Bell, 2014). Mcm7 ubiquitylation was not observed with 
stalled replisomes, suggesting that additional determinants must distinguish elongating 
from terminated replisomes. Further studies are required to properly address the role of 
SCF and Cdc48 and to find other partners possibly involved in this event. 
1.1.4 Archaeal DNA replication 
Most aspects of DNA replication in archaeal species are still unclear. Archaea appear to 
be evolutionary hybrids between Bacteria and Eukarya. For example, the ploidy of the 
genome varies considerably, with some species having a single chromosome with a single 
origin like Bacteria, and others having multiple origins per chromosome (Samson and 
Bell, 2011). Current knowledge of archaeal DNA replication was recently summarised by 
a comprehensive review by Kelman and Kelman (2014). 
The DNA replication apparatus of these organisms shares a lot of similarities with the 
eukaryotic replisome, and represents a "simpler" version of it. Although it was not 
possible to identify a consensus sequence in some archaeal species, similarly to other 
organisms archaeal origin is an AT-rich sequence containing binding sites (ORB, origin 
recognition boxes) for origin recognition proteins.  
Archaeal cells also use AAA+ proteins that are related to the largest subunit of ORC 
complex, Orc1, and to Cdc6. In nearly all Archaea, at least one homolog of the eukaryotic 
Orc/Cdc6 proteins has been identified, which is thought to be involved in both origin 
recognition and helicase loading as evidence suggests a direct interaction with MCM. In 
some Archaea, a Cdt1 homolog (WhiP) has been identified, but it is possible that other 
unknown proteins may also be part of the pre-RC forming the platform for the helicase 
loading.  
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As mentioned before, the archaeal helicase is a homohexamer, but composed of a single 
MCM protein that is related to the eukaryotic MCM2-7. It travels on DNA in the 3’5’ 
direction with a robust activity, and it seems to not require accessory proteins for its 
function (Barry and Bell, 2006). Nevertheless, a CMG complex may also be present in 
Archaea and may play a role in vivo, as homologues of both GINS and Cdc45 have been 
identified. However, while the archaeal GINS proteins are essential for cell viability as 
for Eukarya (Sarmiento et al., 2013), the genes encoding the archaeal Cdc45 can be 
deleted from the chromosome without a major effect on cell growth (Kelman and 
Kelman, 2014). 
The archaeal primase is a two-subunit complex, formed by a small subunit (PriS) 
responsible for the catalytic activity, and a large regulatory subunit (PriL). No 
homologues of the eukaryotic Polα have been identified in archaeal genomes (Lao-Sirieix 
et al., 2005). In contrast to DNA primases from Bacteria and Eukarya that can utilize only 
ribonucleotides, in vitro studies demonstrated that the archaeal primase is capable of 
synthetizing both RNA and DNA primers. Nevertheless, several different assays strongly 
suggest that RNA primers are produced in vivo (Ishino and Ishino, 2012; Lao-Sirieix et 
al., 2005; Matsunaga et al., 2003; Robinson et al., 2004). 
Archaeal SSB proteins, β-clamps and clamp loader are respectively homologues of the 
eukaryotic RPA, PCNA and RFC. In some Archaea species two different DNA 
polymerases have been identified, PolB and PolD, but it is unclear whether both 
polymerases are involved in chromosomal replication, as in Eukarya, or only one of the 
two is, as in Bacteria, with the other polymerase playing a different cellular role (Kelman 
and Kelman, 2014). 
Limited information is available on the mechanism of replication termination in Archaea. 
The circular nature of archaeal chromosomes may suggest a mechanism similar to 
bacterial termination, but a study using Sulfolobus solfataricus suggested that termination 
occurs by random collision of the two replication forks and not at a specific site (Duggin 
et al., 2011).  
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1.2 Structural insights of MCM helicase 
The MCM proteins are members of the AAA+ family of ATPases (ATPases Associated 
with various cellular Activities) and thus use energy derived from cycles of ATP 
hydrolysis to do mechanical work, and can be found in a diverse range of cellular 
processes such as protein transport, folding and degradation, membrane fusion, 
microtubule dynamics, transcription, DNA repair and recombination, as well as DNA 
replication. 
AAA+ proteins generally assemble as higher order oligomers, with a strong preference 
for hexameric rings (Erzberger and Berger, 2006; Ogura and Wilkinson, 2001). The ATP 
binding sites usually consist of residues spanning neighbouring subunits and therefore are 
located at the interface between monomers. This particular arrangement allows to 
generate large movements from small structural changes caused by ATP binding. 
As a AAA+ protein, the MCM helicase also belongs to the general division of P-loop 
NTPases, distinguished by the presence of two functional motifs that are necessary for 
ATP binding and hydrolysis: the Walker A (also known as phosphate-binding loop, or “P 
loop”) and the Walker B motifs. More specifically, the motor core of the helicase consists 
of a particular fold known as ASCE (Additional Strand Catalytic E), characterized by an 
additional strand between the Walker A and Walker B motifs, and by the presence of a 
catalytic glutamate (Leipe et al., 2003; Medagli and Onesti, 2013).  
1.2.1 The general organization of MCM proteins is highly conserved 
MCM proteins are conserved between Archaea and Eukarya, with most Archaea 
possessing a single copy forming homomultimeric  rings, while eukaryotes having at least 
6 different paralogs (MCM2-7) that assemble into a heterohexameric complex. The six 
eukaryotic MCM proteins share significant sequence similarity among species centred in 
the region of the ATPase active site (AAA+ domain) (Konin, 1993). 
A canonical MCM protein can be divided into three domains (Figure 1.5): the N-terminal, 
AAA+ and C-terminal domains. Both the N- and the C-terminal domains are less 
conserved and may present additional apparently unfolded extensions that, especially in 
the eukaryotic members of the MCM family, may have additional regulatory roles and 
mediate further protein-protein interactions. 
17 
 
Archaeal homologs have been for long time the best model system for studying the 
structure and function of the MCM helicases. In fact, despite the fact that some EM maps 
of eukaryotic homologues are available nowadays, the most detailed structural 
information comes from the crystallographic structures of archaeal domains or full length 
archaeal MCM proteins. 
 
Figure 1.5 Primary structure of MCM proteins (adapted from Costa and Onesti, 2009). The 
N-terminal domain is shown in green, AAA+ domain in red, the C-terminal domain in blue. Zn: 
zinc domain, ACL: allosteric communication loop, NBH: N-terminal β-hairpin, EXT: external 
β-hairpin, WA: Walker A, E switch: glutamate switch, H2i: helix 2 insert, WB: Walker B, PS1βH: 
pre-sensor I β-hairpin, SI: sensor I, RF: arginine finger, SII: sensor II. See text for details. 
1.2.1.1 N-terminal domain 
The N-terminal domain has the main role of governor of the helicase activity. While it is 
not strictly required for the unwinding activity, it is critical to determine the range of 
DNA substrates that MCM can melt (Barry et al., 2007). Besides its ability to interact 
with DNA, it is able to influence the processivity of the helicase and is also a strong 
determinant for hexamerization (Barry et al., 2007; Jenkinson and Chong, 2006; 
Kasiviswanathan et al., 2004; Liu et al., 2008; Pucci et al., 2007).  
Fletcher et al. (2003) were the first to provide a structural characterization of this domain 
by crystallising the N-terminal fragment of the MCM protein from 
Methanothermobacter thermautotrophicus (MthMCM). The structure revealed a double 
hexamer with a head-to-head configuration (Figure 1.6). Later on other structures were 
published demonstrating a variety of configurations that this domain can acquire 
(Figure 1.7); S. Solfataricus MCM (SsoMCM) forms a single planar hexamer but can also 
be arranged in a left handed filament; while Thermoplasma acidophilum (TacMCM) 
forms a right handed open ring (possibly representing a state of MCM before loading on 
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dsDNA). More recently the structure of the N-terminal domain of Pyrococccus furiosus 
MCM (PfuMCM) showed for the first time the hexameric ring interacting with a short 
ssDNA and the rearrangement of the central channel upon this interaction, going from an 
symmetric and circular pore to an elliptical shape where not all the subunits are working 
simultaneously. Interestingly, the ssDNA stretch is not pointing out from the central 
channel but is located perpendicular to it. 
 
Figure 1.6 Structure of N-terminal domain of MthMCM (modified from Fletcher et al., 
2003). (A) Side-view of the double hexamer, each monomer represented by a discrete colour; 
α-helices are represented by cylinders, β-strands by arrows. The zinc atoms (pink) mediate 
hexamer-hexamer interactions. (B) View of a monomer, showing subdomain A, B and C (sA, sB, 
sC). See text for details. 
All these structures share common features, like a positively central channel large enough 
to accommodate a dsDNA (with the only exception of the SsoMCM ring) as well as 
particular characteristics for each species, like a short and positively charged helical 
insertion in the proximity of the Zn binding motif in the TacMCM. 
Each N-terminal monomer folds into three different subdomains (Figure 1.6): the 
subdomain A (sA) is located in the peripheral belt of the MCM ring and gives the 
assembly its characteristic “dumbbell” shape. It is a really flexible domain and EM maps 
as well as crystals structures demonstrate that it can undergo from a close to and open 
conformation. 
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The subdomain B (sB) is found at the double-ring interface and contains a conserved Zn 
motif that contributes to the ssDNA binding. It was demonstrated to stabilize the amino-
terminal domain, thus facilitating inter-hexamer interactions (Fletcher et al., 2003; 
Kasiviswanathan et al., 2004), and recent studies in yeast have demonstrated that 
mutations in this motif can impair the formation of the loaded double hexameric MCM 
(Riera et al., 2014).  
 
Figure 1.7 Crystal structures of N-terminal domains from different archaeal organisms. (A) 
S. solfataricus MCM (Liu et al., 2008) (B) T. acidophilum MCM (Fu et al., 2014) (C) P. furiosus 
MCM (ssDNA is shown in cyan, (Froelich et al., 2014)).  
The subdomain C (sC) is responsible for hexamer formation; it contains a β-hairpin 
element (NBH) that points toward the central channel. Biochemical studies demonstrated 
that the β-hairpin is critical for DNA binding, but based on the X-ray structures it is 
evident that this loop is highly flexible and it may play a role also in the rearrangement of 
the domain. The recent published structure of the N-terminal domain of the PfuMCM 
bound to ssDNA allows to identify a series of residues of subdomain C that are important 
for binding to ssDNA and, to a less extent, dsDNA (MSSB, MCM single strand binding 
motif). Mutations of these residues in yeast MCM2-7 are associated to defects in helicase 
loading and activation, suggesting a possible role in initial DNA melting of licensed 
origin (Froelich et al., 2014). The N-terminal domain is also involved in inter-subunit 
communications, as its deletion abolishes the cooperativity between AAA+ domains. This 
role relies on a conserved loop, termed the allosteric communication loop (ACL), situated 
in subdomain C at the interface with the AAA+ domain (Barry et al., 2009; Sakakibara et 
al., 2008). 
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Finally, some eukaryotic MCM proteins are characterised by extended unstructured  
motifs (NSD) at their amino termini, that are involved in regulatory mechanisms, in 
particular for Mcm2, Mcm4 and Mcm6. Those NSD regions are extensively 
phosphorylated by DDK in vitro (Randell et al., 2010). This event was widely 
demonstrated to be a key step in helicase activation and initiation of DNA replication 
(Tanaka and Araki, 2013). In addition, recently EM maps allow us to hypothesize that 
those extensions are involved in the double hexamer ring interaction (Sun et al., 2014) as 
well as the interaction of MCM with Cdc45 in the CMG complex (Costa et al., 2014). 
1.2.1.2 AAA+ domain 
The “core” of the MCM helicase is the central AAA+ domain, which is responsible for 
the catalytic activity of ATP hydrolysis and DNA unwinding. This domain is 
characterised by a series of conserved sequence motifs implicated in ATP binding and 
hydrolysis. The AAA+ domains of MCM2-7 share a common fold, with a α/β 
mononucleotide binding subdomain formed by a series of loops connecting adjacent 
parallel strands (P loop) and containing the motifs involved in binding ATP (Walker A 
box) and orienting the nucleophilic water molecule (Walker B box and sensor 1). A less 
conserved α-helical subdomain called "lid" is positioned C-terminally to the P-loop 
domain and contains motifs that contact the ATP phosphate (arginine finger and sensor 
2). In the MCM helicase the active sites are at the dimer interfaces, with one subunit 
providing the P loop (cis motifs), and the other subunit providing the lid (trans motifs; 
Bell and Botchan, 2013; Costa and Onesti, 2009; Medagli and Onesti, 2013). 
 
Figure 1.8: The active site of the MCM helicase. (A) The ATPase site is located at the interface 
between adjacent subunits, one providing the cis motifs (A: Walker A, B: Walker B) and the other 
providing the trans motifs (R: arginine finger, modified from Costa and Onesti, 2009). (B) The 
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structure of a monomer of SsoMCM provides insights on the architecture of the AAA+ domain 
(adapted from Bell and Botchan, 2013): Orange spheres: cis-acting residues, Black spheres: 
trans-residues, EXT-HP: external hairpin, PS1BH: pre-sensor 1 β-hairpin, H2I: helix 2 insert. 
Details of the N-terminal domain: ACL: allosteric communication loop, NBH: N-terminal 
β-hairpin, Purple spheres: zinc-coordinating residues.  
In addition to the canonical AAA+ sequence motifs, a “glutamate switch” (E switch) 
provides a way to regulate the ATPase activity in a more tightly controlled way. The 
glutamate residues of the Walker B domain, involved in orienting and polarizing a water 
molecule for the nucleophilic attack on the γ-phosphate of the ATP, can form a hydrogen 
bond with a polar residue (typically an asparagine). This alternative interaction ensures 
that the ATPase activity is switched off unless the system is correctly assembled (Costa 
and Onesti, 2009; Zhang and Wigley, 2008). 
A feature that is typical of the MCM proteins is the presence of three DNA interacting β 
hairpin motifs in the AAA+ fold. An external β-hairpin (EXT) at the lateral hole of the 
structure, a helix 2 insertion (H2I) and an insertion before the sensor 1 motif (PS1BH).  
The overall organization of this domain was initially observed by EM map and then in 
two different crystal structures; one high-resolution crystal structure (1.9 Å) but 
belonging to an inactive Methanopyrus Kandleri MCM helicase (MkaMCM) that is 
missing most of the functional motifs in the AAA+ core (Bae et al., 2009), and a second, 
lower resolution structure (4.35 Å), of the functional full length protein from 
S. solfataricus (Brewster et al., 2008). Both proteins were crystallised in their monomeric 
state. A recent crystallographic structure of a chimeric MCM helicase, in which the N-
terminal domain from S. solfataricus is fused to the AAA+ domain from P. furiousus and 
bound to ADP, showed the hexameric conformation of the catalytic core (Miller et al., 
2014).  
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Figure 1.9: Overall arrangement of the hexameric Sso-PfuMCM. Each subunit is shown in a 
different colour. ADP and magnesium are shown in cyan and magenta, respectively. 
As for the N-terminal ring, also the AAA+ domain form a channel that can accommodate 
a dsDNA. The H2I and PS1βH extend into the central pore of the enzyme and undergo 
significant movement during the ATP cycle. There are evidence that both motives are 
involved in the helicase activity. As a subunit goes through its ATP hydrolysis cycle, both 
β-hairpins move, thereby driving the helicase along dsDNA. Biochemical evidences in 
SsoMCM support this hypothesis. (Barry et al., 2009; Bell and Botchan, 2013). In the 
hexameric Sso-PfuMCM (Miller et al., 2014) it is possible to appreciate the proximity of 
the ACL loop with the h2i of the same subunit and the ps1bh of the adjacent one strongly 
supporting the biochemical evidence that indicate this loop is the responsible on the 
intradomain communication.  
1.2.1.3 C-terminal domain 
The C-terminal domain remained the least characterized domain of MCM helicases for a 
long time. While this domain is in general less conserved, sequence analysis of C-
terminal domains of archaeal MCM proteins suggests the presence of a winged-helix 
(WH) domain (Aravind and Koonin, 1999). EM models allowed to locate this domain on 
top of the AAA+ domain, but the weak electron density in the EM as well as the X-ray 
structures suggests high flexibility (Brewster et al., 2008; Costa et al., 2006a, 2006b). 
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In 2010, Wei et al. eventually characterized the C-terminal domain of human Mcm6. The 
high resolution NMR structure confirmed the predicted winged helix fold, which consists 
of a helix-turn-helix (HTH) motif and a wing (β-loop-β) motif. They also identified the 
binding surface and key residues involved in the Cdt1 interaction, which was previously 
demonstrated to play a key role in MCM2-7 loading (reviewed by Bell and Kaguni, 
2013). In fact, single point mutations in that motif disrupt this interaction (Wei et al., 
2010).  
In addition, the archaeal homolog of this domain was shown to have a regulatory effect. 
Deletion of the C-terminal domain showed an increase in helicase and ATPase activity, 
suggesting that it may act as a brake (Jenkinson and Chong, 2006). Recent NMR analysis 
confirmed the winged helix fold also for the C-terminus of MthMCM and SsoMCM 
(Wiedemann et al., 2013).  
 
Figure 1.10: Structure of the Cdt1 binding domain of human Mcm6 (from Wei et al., 
2010). Ribbon representation of the structure using the coordinates of the lowest energy 
NMR structure. α-helices are in red, β-strands in green, loops in cyan and grey. 
N-terminal and C-terminal ends are indicated as N and C, respectively. 
1.2.2 Overall assembly of MCM helicases 
EM models of MthMCM revealed a certain degree of variability. The complex can form 
single or double hexamer structure with a head-to-head orientation, single and double 
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heptameric rings or filaments, later confirmed by crystallographic structures (Pape et al., 
2003; Yu et al., 2002). Changes in the oligomeric state are due to the interaction with 
substrates (oligonucleotides and dsDNA), but also to other factors like temperature, salt 
and protein concentration. However, this MCM homologue showed to be functional in the 
single hexameric state.  
EM reconstructions of hexameric rings of MthMCM revealed a two tiers structure (Costa 
and Onesti, 2009). Docking of the crystallographic structure into the EM envelope 
demonstrates that one tier is composed of the amino-terminal domains, and the other tier 
of the AAA+ domains.  
1.2.2.1  The eukaryotic MCM, from the apo-protein to the loaded form 
The process of helicase loading requires the opening of the MCM2-7 complex and 
insertion of the DNA, before the ring closes around the DNA. 
In vitro studies with S. cerevisiae MCM2-7 revealed that pre-incubation of the complex 
with ATP or a poorly hydrolysable analogue impaired the binding to circular ssDNA but 
had negligible effects on the ability of the complex to bind linear DNA, suggesting the 
existence of a "gate" in the ring that is closed in the presence of ATP, thus preventing the 
DNA to enter in the central channel (Bochman and Schwacha, 2008). A further study 
showed that the impairment was bypassed by mutation of either the Walker A motif of 
Mcm5 or the arginine finger of Mcm2, suggesting that the gate could be localised at the 
interface between these two subunits (Bochman et al., 2008). 
No structural evidence of a gate within the MCM hexamer was initially available, as the 
only eukaryotic EM map (Remus et al., 2009) showed a dodecameric MCM2-7 protein 
loaded on a dsDNA. This map was compatible with EM reconstructions of the archaeal 
homologues and was also consistent with biochemical results indicating the presence of a 
double hexameric protein at the origin. Other EM models obtained more recently allow us 
to have a clearer picture of the steps necessary for the loading of the MCM complex and 
which are the conformational changes that characterise this protein, from the apoMCM 
protein to the loaded MCM form and the finale functional CMG complex. 
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EM reconstructions of Drosophila MCM2-7 provided structural confirmation that the gap 
lays between Mcm2 and Mcm5 (Figure 1.9, Costa et al., 2011). Consistent with previous 
studies on archaeal models, a two-tier structure was observed. However, two distinct 
conformations of MCM2-7 were noticed. One form resembles an almost symmetric ring, 
but possesses a notch in the AAA+ tier. The second and more abundant form had an 
asymmetric opened configuration (also known as “lock washer”) with a gap extending the 
full length of the MCM. The lock washer configuration may correspond to a loading-
competent form of the helicase. Another important confirmation of the presence of the 
gate between Mcm2 and 5 and its role during helicase loading came from biochemical 
studies. It has been showed that the initial formation of the ORC/Cdc6/Cdt1/MCM2-7 
(OCCM) complex can occur when Mcm2 is "linked" to Mcm5, but subsequent ATP 
hydrolysis is prevented and the complex disassembles, thus inhibiting the formation of 
the double hexamer (Samel et al., 2014).  
 
Figure 1.11: The apo-form of Drosophila MCM2-7 forms a gapped ring (adapted 
from Costa et al., 2011). (A) 3D EM reconstruction of the notched ring viewed from the 
AAA+ face. (B) 3D structure of the lock-washer ring viewed from the AAA+. See text for 
details.  
Recent EM studies carried out by Sun et al. on yeast MCM2-7 captured different 
intermediates during the loading process, providing some insights about the structural 
changes in the helicase.  
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Studies on the OCCM complex in presence of ATP-γS show that the ORC-Cdc6 complex 
is tightly associated with the C-terminal AAA+ domains of Cdt1-MCM2-7 (Sun et al., 
2013). The interaction of Cdt1 with MCM2-7 creates a gap in the N-terminal tier of the 
hexamer, by displacing the N-terminal part of Mcm2 away from Mcm5. The OCCM is a 
transient complex, as Cdt1 is immediately released upon ATP hydrolysis to form the 
OCM complex. Here ORC–Cdc6 and MCM2-7 appear to be more closely engaged (Sun 
et al., 2014). This could reflect a functional difference, as the OCM, is now competent to 
accept another MCM2-7 hexamer. A novel intermediate, the OCMM complex (formed by 
OCM and a second MCM2-7 hexamer), was also identified, shedding light on another 
step toward the assembly of a double hexamer on the origin (Figure 1.10).  
 
 Figure 1.12: Intermediates during the stepwise recruitment of MCM2-7 onto DNA 
(adapted from Sun et al., 2014). EM visualization of OCCM (left), OCM (central) and 
OCMM (right) complex. The presence of Cdt1 was captured in presence of ATPγS, as 
OCCM is short-lived. CT: C-terminal domains, NT: N-terminal domains. 
Sun et al. also provided a detailed description of the final product of the loading process, 
(i.e. the MCM2-7 double hexamer, Figure 1.11). Within each hexamer, the C-terminal 
domains have a 30° tilt toward the right relative to the N-terminal domains, creating a 
twisted structure. As the ATPase activity relies on the accurate positioning of catalytic 
residues from neighbouring subunits, this arrangement would prevent ATP hydrolysis, 
thus promoting a long-term stability of the double hexamer on the licensed origin during 
the G1 phase. This hypothesis is supported by the markedly reduced ATPase activity of 
the double hexamer in vitro (Sun et al., 2014). 
It is possible to notice the extended C-terminal domain of Mcm3 protruding from the 
double hexamer above the AAA+ domain; this domain is responsible for the interaction 
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with ORC/Cdc6. The N-terminal domain of several subunits, on the other hand, protrudes 
toward the AAA+ domains of the hexamer, and this is more evident for the MCM with 
longer extensions. 
The hexamers respect to each other are staggered of 20 Å and tilted of 5°: this twisted 
structure seems a peculiarity of the eukaryotic double hexamer, as there is no evidence of 
this arrangement in the archaeal counterpart. 
 
Figure 1.13: EM side views of the MCM2-7 double hexamer (adapted from Sun et 
al., 2014). (A) Front view, the six Mcm proteins are shown in different colours. (B) Back 
view, the N-terminal domains of Mcm2, 4 and 6 create a helical arrangement (traced by 
blue lines). (C) Schematic representation of the arrangement of the two hexamers.   
This structure is characterized by a staircase-like arrangement of the N-terminal domains 
of Mcm2, Mcm6, Mcm4 due to their proximity, constituting in this way a docking 
platform for the DDK. Consistently, the double hexamer was demonstrated to be a better 
substrate of DDK than the single hexamer in vitro (Sun et al., 2014), explaining also how 
the N-terminal parts of Mcm2 and Mcm4 are directly involved in the mechanism of 
helicase activation during origin firing. In addition this structure demonstrates that the 
gate between Mcm2 and Mcm5 is locked by the interaction with Mcm4; this can 
represent a further mechanism to avoid the premature activation of the helicase. 
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1.2.2.2 Organization and structural insights into the CMG complex 
The conformational changes that underlie the conversion of the loaded double hexamer 
into two active helicases are is still unknown. 
First insights on the overall organization of the CMG complex were provided by Costa et 
al. in 2011 (Figure 1.12). The first EM model of Drosophila CMG revealed that MCM2-7 
within the complex adopts a notched ring conformation, previously shown also by the 
apoMCM2-7. The notch was further narrowed by incubation with ADP•BeF3. Moreover, 
the additional density on the side of the ring, identified as GINS/Cdc45, embraced Mcm3, 
Mcm2 and 5 that form the gap. These observations suggested that the enhanced ATPase 
and helicase activity measured for the CMG complex with respect to MCM2-7, could be 
due to the closure of the gate, enabling a proper repositioning of the ATPase active sites.   
 
Figure 1.14: EM reconstruction of the Drosophila CMG complex (adapted from 
Costa et al., 2011). (A) Apo-CMG, showing a discontinuity between MCM2/5. (B) CMG 
complex bound to ADP•BeF3, showing a pinched-off gap.   
More recently, a higher resolution map for the CMG with DNA and ATPγS was obtained 
allowing a more accurate fitting of the subunits (Costa et al., 2014). In this map it is 
possible to appreciate that the AAA+ domains display a certain degree of freedom with 
respect to the associated N-terminal regions, demonstrating that these elements are to 
some extent conformationally independent from each other in the presence of DNA 
substrates (Figure 1.13). The AAA+ ATPase tier adopts a clear right-handed spiral 
conformation, while the N-terminal tier remains almost planar, supporting the hypothesis 
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that the N-terminal domains could coordinate and restrain the movements of the 
associated C-terminal regions. This is consistent with the conformation reported for the 
loaded yeast double hexamer (Sun et al., 2014), raising the hypothesis that this 
arrangement could be driven by the interaction with the DNA. GINS/Cdc45 may play a 
role in stabilising this spiral configuration, which could have important implications for 
DNA unwinding.   
 
Figure 1.15: Interdomain flexibility in CMG-DNA-ATPγS complex (adapted from 
Costa et al., 2014). The N- and C-terminal domains of MCM2-7 (colours) differentially 
flex around the helicase ring, with GINS-Cdc45 wedging open MCM5 in particular. See 
text for details.  
The authors also reported a small (∼5%) but consistent population of dimeric CMG 
particles with a clear head-to-head configuration through the N-terminal regions, which 
could represent another step of the helicase activation, just before the separation of the 
two replication forks (Figure 1.14). The two GINS–Cdc45 subcomplexes (thus, the two 
MCM2/5 gates) are placed at opposite sides of the two rings. During origin melting, this 
configuration would allow a single DNA strand to escape each MCM2-7 hexamer without 
steric interference from its CMG partner, enabling particle separation and the formation 
of two independent replication forks. Moreover, this arrangement suggests that the ability 
of DDK to activate MCM2-7 by phosphorylation of Mcm4 and 2 could result from a 
destabilization of the CMG dimer contacts at the N-terminal collar and indicates that 
separation of Mcm2-7 double hexamers occurs subsequently to CMG formation. Such a 
mechanism is consistent with recent findings showing that phosphorylation by DDK is 
insufficient to promote the separation of MCM2-7 double hexamers (On et al., 2014). 
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Figure 1.16: Cartoon representation of the dimeric CMG complex (from Costa et al., 
2014). Each MCM protein is shown in a different colour, GINS/Cdc45 are shown in 
violet. See text for details.  
1.3 Biochemical properties of MCM helicases 
1.3.1 The archaeal helicase 
Because of the complex nature of the eukaryotic MCM2-7 assembly, a first and detailed 
biochemical characterization has been carried out on the homohexameric MCM 
complexes of Archaea. The MCM complex hydrolyses ATP and this activity is stimulated 
by the addition of either ssDNA or dsDNA (Bochman and Schwacha, 2009). It binds 
DNA in an ATP/Mg
2+
-dependent manner, without sharing a preference for the substrate. 
For example, MthMCM slightly prefers ssDNA over dsDNA (Sakakibara et al., 2008), 
while SsoMCM prefers substrates that contain both ssDNA and dsDNA, as both forks and 
bubbles are preferred over simple ssDNA probes (Pucci et al., 2004; Rothenberg et al., 
2007).  
Archaeal complexes show a robust 3’5’ helicase activity, that is dependent on ATP and 
Mg
2+
 and which demonstrates very little DNA substrate specificity: blunt, singly tailed, 
and forked substrates are all similarly unwound (Bochman and Schwacha, 2009). 
Fluorescence resonance energy transfer experiments demonstrated that the hexamer 
encircles the 3’ tail of forked DNA probes and then slides toward the duplex region of the 
fork (McGeoch et al., 2005). The relative orientation of the complex was also studied, 
showing that the AAA+ domain is facing the dsDNA junction of the fork and the 
N-terminus is closer to the end of the 3’ tail (Rothenberg et al., 2007).  
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1.3.2 The eukaryotic helicase 
MCM2-7 has been shown to be bound to the chromatin in the G1 phase, displaced during 
the S phase and absent on the chromatin in the G2 phase. Despite evidences that MCM2-7 
is required for initiation and elongation of DNA replication in vivo (Labib et al., 2000), 
attempts to reproduce its helicase activity in vitro have been unsuccessful. Instead, a 
specific dimeric heterotrimer (Mcm4/6/7), isolated from a variety of systems and formed 
by two copies each of the Mcm4, Mcm6, and Mcm7 subunits, possessed an ATP-
dependent, DNA-unwinding activity with 3’5’ directionality (Ishimi, 1997; Kaplan et 
al., 2003; Lee and Hurwitz, 2000; You et al., 2002). This complex binds DNA in a ATP-
dependent way with a strong preference for ssDNA, suggesting that Mcm2/3/5 have a 
regulatory role in the complex. 
Further studies on MCM2-7 revealed that the replacement of chloride with either 
glutamate or acetate in the buffer reconstitutes the DNA-unwinding activity (Bochman 
and Schwacha, 2008). The DNA binding activity of MCM2-7 largely depends on when 
ATP is added to the reaction mixture: if ATP is added before DNA, low levels of binding 
are detected, while higher levels are observed when ATP is added after DNA. This 
difference suggestest the existence of a gate in the ring of MCM2-7, which could 
facilitate the binding of ssDNA to the central channel and could also justify the lacking of 
helicase activity in vitro: an open conformation would prevent  propagation through the 
ring of all necessary conformational changes required for DNA unwinding (Erzberger and 
Berger, 2006) Interestingly, pre-incubation of MCM2-7 with glutamate preferentially 
reduces circular ssDNA binding, mimicking the pre-incubation effect with ATP, and it is 
consistent with the notion that the closed form of MCM2-7 is required for helicase 
activity (Vijayraghavan and Schwacha, 2012). Subsequent EM studies confirmed the 
existence of a gap between Mcm2 and Mcm5, both in S.cerevisiae and Drosophila 
MCM2-7 (Costa et al., 2011; Samel et al., 2014).    
A stable complex was subsequently purified from Xenopus eggs including MCM2-7, 
GINS and Cdc45, which possessed robust helicase activity in vitro, demonstrating 
unambiguously that MCM2-7 is a functional helicase and that the cofactors (GINS and 
Cdc45) are essential for its activity (Ilves et al., 2010; Moyer et al., 2006).  
The CMG helicase translocates in a 3’5’ direction on single-stranded DNA (Moyer et 
al., 2006) and shows higher biochemical activity compared to MCM2-7: the rate of ATP 
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hydrolysis is about 300 fold higher, the helicase activity is robust on circular templates 
and the affinity for DNA substrates is improved (Ilves et al., 2010). As also supported by 
subsequent structural studies (Costa et al., 2011, 2014), the activation by GINS and 
Cdc45 is most likely achieved through allosteric remodelling of the MCM ring to 
optimize subunit interactions for higher hydrolysis rates. Consistently, single mutation in 
critical residues of MCM2, 3, 5, or 7 decreases ATPase rates of the entire CMG, 
demonstrating that the MCM subunits do not work independently, as previously shown 
for S. cerevisiae MCM2-7 (Ilves et al., 2010; Schwacha and Bell, 2001). In contrast to 
MCM2-7, the ATPase activity of the CMG complex is not stimulated by DNA and this 
may be explained by the fact that the active sites have an optimal conformation in the 
CMG. 
More recently, the human CMG complex was also characterised biochemically (Kang et 
al., 2012). Like the Drosophila CMG complex, it translocates in a 3′5′ direction and 
requires magnesium and ATP to bind ssDNA. Human CMG is  most active with forked 
DNA substrates containing oligo(dT) sequences on the 3′ strand, and both helicase and 
DNA-binding activities increase significantly as the length of the 3′ single stranded tail 
increases. The human CMG complex is able to in vitro displace duplex regions up to 500 
bp, and the duplex length was shown to increase substantially in the presence of single 
strand binding proteins. 
1.4 MCM proteins and cancer 
Alteration in the DNA replication process are widely recognised as triggering factors for 
uncontrolled cellular proliferation, and many replication factors (like topoisomerases, 
DNA polymerases and PCNA) are clinical targets of cancer treatment (Simon and 
Schwacha, 2014). As the only replication factor required for both licensing and DNA 
unwinding, MCM2-7 is a major cellular regulatory target and is therefore a potential 
chemotherapeutic target for cancer treatment. MCM mutations are associated to genomic 
instability in yeast and have been shown to cause cancer in mouse models. Moreover, 
high expression levels of MCM proteins strongly correlates with poor prognosis for many 
different tumours; therefore MCM proteins are proposed as novel prognostic and 
diagnostic markers in clinical practice. 
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1.4.1 MCM proteins are involved in tumourigenesis 
First evidences about the importance of MCM2-7 for genome stability derived from 
studies in yeast. Mcm mutations cause plasmid loss, DNA damage and increased 
recombination in S. cerevisiae (Gibson et al., 1990; Hennessy et al., 1991; Maine et al., 
1984), while S. pombe Mcm mutants have been shown to accumulate DNA repair foci, 
which are diagnostic of DNA double strand breaks (Bailis et al., 2008).  
Studies in both mice and human cells indicate that either duplication and overexpression 
of Mcm genes can contribute to cancer development (Chuang et al., 2010; Ren et al., 
2006). These findings were recently confirmed by high-throughput sequencing of various 
cancerous tissues, which demonstrated that amplification of at least one of the Mcm genes 
is relatively common (Simon and Schwacha, 2014).  
Reduction in Mcm2-7 expression levels has also been linked to cancer. The ablation of 
one of the two gene copies of either Mcm2, 3, 4, or 6, in mice caused reduced MCM 
protein levels, growth retardation, and reduced proliferation, confirming that, as in 
budding yeast, MCM protein levels are critical for normal growth in metazoans. 
Consistent with genomic instability studies in yeast (Lei et al., 1996; Liang et al., 1999), a 
reduction of Mcm2 expression in transgenic mice caused fatal lymphomas (Kunnev et al., 
2010; Pruitt et al., 2007) 
Additionally, Mcm point mutations are common in tumours, but in most cases it is unclear 
if they cause a general reduction in DNA replication potential, or a specific loss of MCM 
regulation. Currently, two mutations of the Mcm4 gene have been extensively 
characterised. The first mutation, known as Mcm4
chaos3
 (Mcm4
F345I
), caused mammary 
tumours in mice (Kawabata et al., 2011; Kunnev et al., 2010) and the corresponding 
S. cerevisiae mutant induced plasmid loss, genomic instability and reduced viability 
(Kunnev et al., 2010; Li and Tye, 2011). In this case, the mutation generated MCM2-7 
complexes with reduced physical stability, suggesting a nonspecific reduction of DNA 
replication potential (Kawabata et al., 2011). In contrast, the second identified mutation 
(Mcm4
D573H
) involves an amino acid of the universally conserved Walker B ATPase 
motif, whose substitution generates a dominant change of functional allele that poisons 
the normal MCM2-7 helicase activity (Bagley et al., 2012).  
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Overall, these studies provide strong evidence of a connection between MCM2-7 and 
cancer development. Thus, the modulation of its activity may be an avenue for the 
development of novel therapeutics. 
1.4.2 MCM proteins as diagnostic and prognostic markers 
Since MCM proteins are absent in quiescent cells but abundant in active mitotic cells 
(Madine et al., 2000), many groups investigated the potential use of MCM2-7 as a marker 
for cancer (Freeman et al., 1999; Stoeber et al., 2001).  
Numerous studies validated the MCM proteins as excellent prognostic and diagnostic 
markers. The expression of Mcm2, for example, was shown to correlate with the survival 
rate and prognosis in several human malignancies, such as oral, lung, ovarian, breast, 
renal, prostatic, urothelial and neurological carcinomas (Giaginis et al., 2010). Elevated 
expression of Mcm5 in urine sediments were shown to be a predictive factor for bladder 
and prostate cancers; Mcm7 was shown to be a biomarker for cervical cancer; Mcm5 and 
Mcm6 were shown to be prognostic markers in patients with ovarian cancer and 
melanoma, respectively (Kwok et al., 2015). Most studies identified MCMs expression as 
a negative predictor for patient survival (Giaginis et al., 2010). 
In the last few years, many evidences revealed that MCM proteins are characterized by 
higher specificity and sensitivity than other conventional proliferative markers. Data 
indicate that MCMs are able to detect more proliferating cells than Ki-67 or PCNA 
markers, that are routinely used in clinical practice. Therefore, MCM proteins could be 
potentially better candidates for marking proliferating cells. However, it is important to 
notice that studies performed so far never used a standard definition for MCM expression. 
Thus, it is extremely important to define a standard criterion, as well as to establish 
precise cut-off points for MCM expression levels in order to exploit MCMs as a 
diagnostic and prognostic factor in routine clinical settings (Giaginis et al., 2010).  
1.4.3 MCM proteins as targets for therapeutic agents 
As the MCM2-7 complex contains six unique ATPase active sites and binds numerous 
regulatory proteins, it is a promising target for blocking the proliferation of cancerous and 
pre-cancerous cells. However, no high-throughput biochemical screens have been 
performed on the eukaryotic replicative helicase, since it is difficult to purify MCM2-7 or 
the CMG complex in large amounts to perform these studies. 
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To date, only few compounds have been identified using low-throughput approaches. For 
example heliquinomycin, that was originally identified as an inhibitor of in vitro 
replication in cell extract systems (Chino et al., 1996), was later shown to inhibit the 
DNA unwinding properties of MCM4/6/7. It may also have a similar effect on MCM2-7, 
as it is able to selectively decrease proliferation of cancer cells overexpressing Mcm7 in 
tissue cultures (Toyokawa et al., 2011). 
More recently, ciprofloxacin and related compounds, belonging to the family of 
fluoroquinolones, were found to selectively inhibit the MCM2-7 helicase activity in vitro 
(Simon et al., 2013). Concentration levels of ciprofloxacin comparable to those that block 
helicase activity in vitro, were able to inhibit proliferation of both yeast and human cells, 
supporting the possibility that MCM2-7 was also the cellular target of this compound.  
Since fluoroquinolones have a long history of use as antibiotics and much of their 
pharmacological properties  are understood (Oliphant and Green, 2002), the development 
of these molecules as inhibitors of MCM2-7 is an attractive strategy. In order to elucidate 
the structure-activity relationship between MCM2-7 and fluoroquinolones and to find 
inhibitors more potent than ciprofloxacin, a library of compounds with similar structures 
was tested biochemically for MCM2-7-mediated DNA unwinding. Although no inhibitors 
of higher specificity than ciprofloxacin have been identified, inhibitors of higher potency 
have been obtained (Simon et al., 2013). 
The development of MCM2-7-specific inhibitors is at an early stage, and the structure-
activity relationship of these compounds is still poorly understood. Recent developments 
using whole-cell assays suggest ways to conduct such targeted MCM2-7 screens to 
identify novel inhibitors with therapeutic potential (Simon and Schwacha, 2014). 
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2 AIM OF THE THESIS 
Consistently with the importance of their role during DNA replication, mutation of 
human MCM2-7 proteins or variation in their level of expression are tightly associated to 
genomic instability and tumour onset (Bagley et al., 2012; Giaginis et al., 2010; 
Kawabata et al., 2011). These proteins have been recently proposed as possible target for 
cancer therapy (Simon and Schwacha, 2014) and the availability of a high resolution 
crystal structure would facilitate the design of possible inhibitors. Therefore, the primary 
aim of this project is to obtain a soluble form of the human MCM proteins for 
crystallisation and biochemical studies.  
In order to reach the amounts of protein and the level of purity and homogeneity required 
for crystallisation, we decided to reduce the complexity of our target by cloning and 
expressing the AAA+ domain and N-terminal domain of each polypeptide separately. 
Constructs have been tested for protein expression in Escherichia coli under a variety of 
conditions, further optimized to increase the level of protein production. Different 
purification strategies were applied to reconstitute recombinant soluble hetero-multimeric 
complexes.  
Soluble proteins have been biochemically and biophysically characterised, and 
crystallization experiments have been carried out in order to obtain crystals suitable for 
X-ray diffraction.  
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3 MATERIALS AND METHODS 
3.1 Reagents and chemicals 
Phusion DNA polymerase and DpnI were obtained from New England Biolabs, and Taq 
DNA polymerase from Invitrogen. IPTG (dioxan free) was purchased from Carbosynth. 
AEBSF and ampicillin were purchased from SERVA. InstantBlue was obtained from 
Expedeon. Lysozyme (from chicken egg white), DNAse I and BSA (for Western Blots) 
were all purchased from Sigma-Aldrich. All other buffers, salts and reagents used for the 
preparation of solutions were purchased from Sigma-Aldrich, unless otherwise stated. 
3.2 Cloning, expression and purification of AAA+ domains 
3.2.1 Cloning 
3.2.1.1 Vectors  
pBluescript plasmids containing the full-length sequences of human Mcm proteins are a 
kind gift from Dr. Francesca Pisani and were used as donor plasmids for Restriction Free 
(RF) cloning. Fragments corresponding to the AAA+ domains were cloned separately in 
the Champion pET SUMO/CAT vector (Invitrogen). Polycistronic constructs were also 
generated by cloning sequentially AAA+ domains of Mcm3/5/2 in pET Duet-1 vector 
(Novagen) and AAA+ domains of Mcm7/4/6 in pCOLA Duet-1 vector (Novagen).  
3.2.1.2 Primers 
Primers for RF cloning were designed to have a 3’ half overlap to the sequence of the 
gene of interest and a 5’ half overlap to the desired insertion site of the destination vector, 
as described in Unger et al., 2010. All primers were purchased from Sigma-Genosys 
(Table 3.1).  
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Table 2.1: List of primers for RF cloning.  Sequences overlapping to the destination vector and 
stop codons are shown in blue and red, respectively; sequences overlapping to the DNA insert are 
shown in black.  
Name of primer DNA sequence (5’ to 3’) 
Destination 
vector 
MCM2_V451_F GCTCACAGAGAACAGATTGGTGGTGTTGCTGTAGGGGAACTGAC pET 
SUMO/CAT 
MCM3_A272_F GCTCACAGAGAACAGATTGGTGGTGCTCAGCCCTCTTTCTCTGC pET 
SUMO/CAT 
MCM4_A436_F GCTCACAGAGAACAGATTGGTGGTGCAGAACAGAAACTTTTTTC pET 
SUMO/CAT 
MCM5_G305_F GCTCACAGAGAACAGATTGGTGGTGGCTCTGGCCGCAGCTTTGC pET 
SUMO/CAT 
MCM6_T321_F GCTCACAGAGAACAGATTGGTGGTACAGCTGAGAGCATTAAGAA pET 
SUMO/CAT 
MCM2_S809_R GAATAAATACCTAAGCTTGTCTCTAGCTGAACTTCTGTGTGTCTA pET 
SUMO/CAT 
MCM3_K660_R GAATAAATACCTAAGCTTGTCTCTACTTCTCCAGAACCTTCTTAA pET 
SUMO/CAT 
MCM4_P776_R GAATAAATACCTAAGCTTGTCTCTAGGGATCAGTTGCAGACTGCT pET 
SUMO/CAT 
MCM5_G655_R GAATAAATACCTAAGCTTGTCTCTAACCGGACAAGGCAGCATCCA pET 
SUMO/CAT 
MCM6_D663_R GAATAAATACCTAAGCTTGTCTCTAATCAGGTGTTTCCACACGGA
T 
pET 
SUMO/CAT 
MCM3_pET_F AGCAGCCATCACCATCATCACCACGCTCAGCCCTCTTTCTCTGCT pET Duet-1 
MCM3_pET_R GCGCCGAGCTCGAATTCGGATCTACTTCTCCAGAACCTTCTTAAA pET Duet-1 
MCM5_pET_F AGGTCGACAAGCTTGCGGCCAAGGAGATATACCATGGGCTCTGGC
CGCAGCTTTGCT 
pET Duet-1 
MCM5_pET_R ACTTTCTGTTCGACTTAAGCACTAACCGGACAAGGCAGCATCCAA pET Duet-1 
MCM2_pET_F AGTTAAGTATAAGAAGGAGATATACATATGGTTGCTGTAGGGGAA
CTGACC 
pET Duet-1 
MCM2_pET_R TTTCGCAGCAGCGGTTTCTTTCTAGCTGAACTTCTGTGTGTCTAT pET Duet-1 
MCM7_pCOLA_F AGCCATCACCATCATCACCACAGTGAGGATGATGAGTCTGGG pCOLA Duet-1 
MCM7_pCOLA_R GCGCCGAGCTCGAATTCGGATCTAGTCTCCTAGAAGAGAGTCCTT
TG 
pCOLA Duet-1 
MCM4_pCOLA_F CAGGTCGACAAGCTTGCGGCCAAGGAGATATACCATGGCAGAAC
AGAAACTTTTTTCA 
pCOLA Duet-1 
MCM4_pCOLA_R ATTACTTTCTGTTCGACTTAAGCACTAGGGATCAGTTGCAGACTGC
TTCA 
pCOLA Duet-1 
MCM6_pCOLA_F AGTTAAGTATAAGAAGGAGATATACATATGACAGCTGAGAGCATT
AAGAAC 
pCOLA Duet-1 
MCM6_pCOLA_R TTTCGCAGCAGCGGTTTCTTTCTAATCAGGTGTTTCCACACGGATG
A 
pCOLA Duet-1 
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3.2.1.3 Restriction Free (RF) cloning 
1
st
 PCR: generation of megaprimers 
Primers listed above were used to amplify the sequences of interest from the donor 
plasmids, as previously described in Unger et al. (2010), to generate a set of megaprimers 
for the second amplification reaction. The amplification was performed using Phusion 
DNA polymerase. PCR conditions for target amplification were as follows: a single 
denaturation step (98°C, 1 min) was followed by 40 cycles of denaturation (98°C, 30 s), 
annealing (45°C, 30 s in the first 10 cycles and 60°C, 30 s in the following 30 cycles), and 
elongation (72°C, 1 min), and a final elongation step of 10 min at 72°C. PCR products 
were separated from unspecific fragments on agarose gel based on their expected size, 
and purified using the QIAquick Gel Extraction Kit (Qiagen) following the manufacturer 
protocol.    
2
nd
 PCR: construct generation  
Double-stranded megaprimers from the first PCR anneal to the destination vector at a 
predesigned position and are extended in a linear amplification reaction to form a double 
stranded nicked-plasmid. The RF reaction was performed with the Phusion DNA 
polymerase as follows: a single denaturation step (98°C, 1 min)  followed by 30 cycles of 
denaturation (98°C, 30 s), annealing (60°C, 1 min), and elongation (72°C, 5 min), and a 
final elongation step of 7 min at 72°C. Parental DNA was then removed from the reaction 
products by digestion with DpnI.  
Screening of positive clones 
Newly synthesized plasmids were used to transform E. coli DH5α cells (Life technology), 
subsequently plated on LB agar with the proper antibiotic for plasmid selection. Positive 
clones were identified by PCR screening. Briefly, single colonies were collected from the 
plate, resuspended in 10 µl of water and boiled for 10 min to lyse cells. The mixture for 
PCR with Taq polymerase was directly added to the cell lysate. The amplification of the 
DNA insert was performed with the same primers of the first PCR, with the following 
conditions: a single denaturation step (98°C, 1 min) followed by 15 cycles of denaturation 
(98°C, 30 s), annealing (60°C, 30 s), and elongation (72°C, 90 s), and a final elongation 
step of 10 min at 72°C. PCR products were run on agarose gel and positive clones were 
identified by the presence of the band corresponding to the amplified DNA insert.   
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Positive clones were amplified in E. coli and plasmids were extracted using the QIAprep 
Spin Miniprep Kit (Qiagen). Further confirmation of the presence of the DNA insert was 
achieved by DNA sequencing. 
3.2.1.4  Generation of polycistronic constructs 
The sequences of AAA+ domains of Mcm7/4/6 and Mcm3/5/2 were cloned in pACYC 
Duet-1 and pET Duet-1 vectors, respectively. Both plasmids are actually designed to 
express two sequences, as they possess two promoters. Thus, the sequences of AAA+ 
domains of Mcm4 and Mcm5 were cloned downstream to Mcm7 and Mcm3, in order to 
create in both cases a unique transcript with two different ribosome binding sites 
(Figure 3.1).  
The sequences were inserted by RF cloning in the following  stepwise manner: after 
cloning the sequences of Mcm7 and Mcm3, positive clones were selected and used as 
recipient plasmids for a second reaction, to insert Mcm4 and Mcm5. The procedure was 
repeated to finally clone also Mcm6 and Mcm2. PCR conditions were analogous to those 
described above. 
  
 
Figure 2.1: Schematic representation of polycistronic constructs. pACYC Duet-1 and pET 
Duet-1 vectors possess two promoters (green arrows). The first subunit of interest (Gene 1) is 
fused in frame to the 6-Hystidine coding region.  The second subunit and a new ribosome binding 
site (RBS, orange box) are inserted downstream of Gene 1 but upstream of the transcription 
terminator sequence of the first expression cassette. The third subunit is cloned in the second 
expression cassette of the vector.  
3.2.1.5 In-Fusion cloning of Mcm7 construct  
The sequence of the AAA+ domain of human Mcm7 was cloned at the Oxford Protein 
Production Facility UK (OPPF-UK) using the In-Fusion PCR Cloning Kit (Clontech). 
Briefly, PCR primers were designed to have 15 base extensions that are complementary 
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to the ends of the linearized cloning vector. These primers were used to amplify the DNA 
insert by PCR. The resulting PCR product was combined with the linearized vector in the 
In-Fusion cloning reaction, consisting of a 30 min incubation with the In-Fusion enzyme. 
This enzyme creates single stranded DNA regions at the ends of the vector and PCR 
product, which are then fused due to the complementarity of the overhanging strands.  
The sequence was cloned into four expression vectors of the pOPIN Suite, kindly 
provided by the OPPF (pOPINF, pOPINM, pOPINS3C and pOPINE). The characteristics 
of these constructs are listed in Table 3.2. 
Table 2.2: List of constructs for expression of the AAA+ domains. A summary of all the 
monocystronic and polycistronic constructs is provided, together with their most important 
properties (antibiotic resistance, typology of tag, weather it is cleavable or not, and by which 
protease).     
Constructs for independent expression 
Name DNA insert Plasmid Resistance Tag Cleavability 
A2 
AAA+ domain 
of Mcm2 
(V451-S809) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
A3 
AAA+ domain 
of Mcm3 
(A272-K660) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
A4 
AAA+ domain 
of Mcm4 
(A436-P776) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
A5 
AAA+ domain 
of Mcm5 
(G305-G655) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
A6 
AAA+ domain 
of Mcm6 (T321-
D663) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
A7-F 
AAA+ domain 
of  Mcm7 
(S309-D647) 
pOPINF Ampicillin 6His Yes (3C protease) 
A7-M 
AAA+ domain 
of  Mcm7 
(S309-D647) 
pOPINM Ampicillin 
6His-
MBP 
Yes (3C protease) 
A7-C 
AAA+ domain 
of  Mcm7 
(S309-D647) 
pOPINS3C Ampicillin 
6His-
SUMO 
Yes (3C protease) 
A7-E 
AAA+ domain 
of  Mcm7 
(S309-D647) 
pOPINE Ampicillin 
6-His 
(C-term) 
No 
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Constructs for co-expression 
Name DNA insert Plasmid Resistance Tag 
Cleavability 
 
Mcm3/5/2 
AAA+ domain 
of Mcm3 
(A272-K660) 
pET Duet-1 Ampicillin 6His No 
AAA+ domain 
of Mcm5 
(G305-G655) 
pET Duet-1 Ampicillin /  
AAA+ domain 
of Mcm2 
(V451-S809) 
pET Duet-1 Ampicillin /  
Mcm7/4/6 
AAA+ domain 
of  Mcm7 
(S309-D647) 
pCOLA 
Duet-1 
Kanamycin 6His No 
AAA+ domain 
of Mcm4 
(A436-P776) 
pCOLA 
Duet-1 
Kanamycin /  
AAA+ domain 
of  Mcm6 
(T321-D663) 
pCOLA 
Duet-1 
Kanamycin /  
 
3.2.2 Small scale expression tests 
AAA+ domain constructs were tested for soluble protein expression under a variety of 
conditions, trying different E. coli strains, induction methods and growth temperatures, as 
summarized in Table 3.3. Monocystronic constructs were expressed individually, while 
polycistronic constructs were expressed both separately and together.  Different bacterial 
strains were used to increase the chances of success:  
 BL21 (DE3) pLysS (Invitrogen): they constitutively express the T7 lysozyme, a 
natural competitor of the T7 RNA polymerase, therefore suppressing any basal 
expression of the protein of interest and allowing a tight control over the 
induction.   
 BL21 (DE3) Codon Plus RIPL (Stratagene): they harbour a plasmid for the 
expression of 6 tRNAs for codons rarely used in E. coli that most frequently limit 
translation of heterologous proteins.  
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 Arctic (DE3) RP (Agilent Technologies): they express cold-adapted chaperonins 
from Oleispira Antarctica that confer improved protein processing at lower 
temperatures, potentially increasing the yield of soluble proteins. 
 Rosetta2 (DE3) pLysS (Novagen): they combine the characteristics of BL21 
pLysS and BL21 Codon Plus RIPL. 
Classical induction was performed by inoculating 10 ml of Luria Broth (LB) or Terrific 
Broth (TB), added with proper antibiotics, with single colonies of E. coli cells harbouring 
the plasmid(s) being tested. Cells were grown at 37°C in 50 ml shaking falcon tubes to 
allow proper aeration. Protein synthesis was induced by adding IPTG when cell density 
reached OD~0.6, and temperature was set at the desired value.  
Protein production by auto-induction was performed by inoculating 4 ml of auto-inducing 
medium LB 5052. Cells were grown in shaking 24-well deepwell plates (Whatmann), 
sealed with a gas permeable membrane filter (Qiagen). Induction is automatically 
achieved when cells start to metabolize the lactose present in the medium, after depletion 
of glucose, as described in Studier, 2005.  
For each tested condition, 5 ml of culture were pelleted and cells resuspended  in 1 ml of 
Lysis Buffer A. After incubation for 1 h at 4°C, samples were frozen and thawed 3 times 
to break cells and centrifuged for 30 min at 15000 g. The soluble fraction was incubated 
for 1 h at 4°C with 10 µl of Ni-NTA Agarose resin (Qiagen), previously equilibrated with 
Buffer A. The resin was then washed twice with 100 µl of Buffer A and bound proteins 
were eluted with 50 µl of 250 mM imidazole in Buffer A. Collected fractions were 
analysed by SDS-PAGE. 
Table 2.3: Summary of conditions tested for the expression of AAA+ domains.  
E.coli strain 
Rosetta2 (DE3) pLysS  
BL21 (DE3) pLysS  
BL21 codon plus (DE3) RIPL  
Arctic RP  
Induction method 
Autoinduction 
IPTG (1 mM-0.5 mM-0.25 mM-0.1 mM) 
Expression time 3 h-6 h-18 h-24 h 
Expression temperature 25°C-17°C-13°C 
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3.2.3 Protein expression for large scale purification 
All AAA+ domains were expressed independently in Rosetta2 pLysS strain. Each AAA+ 
domain of Mcm from 2 to 6 was expressed in 1.2 L of TB, while AAA+ domain of 
Mcm7, cloned in the pOPINM plasmid, was expressed in 0.5 L of TB. Cells were grown 
at 37°C until OD600 reached approximately 0.6. Protein expression was induced by adding 
0.1 mM IPTG and cells were grown overnight at 17°C.  
Co-expression of AAA+ domains was achieved by transforming BL21 pLysS strain with 
both pET and pCOLA Duet-1 vectors. Cells grew in 0.5 L of TB at 37°C until OD600 
reached 1.5. Proteins were expressed at 25°C for 4 h after addition of 0.3 mM IPTG.  
Cells were harvested by centrifugation and the pellet was stored at -80°C.   
3.2.4  Protein purification 
Protein purification was performed using a ÄKTA purifier Fast Protein Liquid 
Chromatography (FPLC) apparatus (GE Healthcare), unless stated otherwise. All protein 
purification steps were carried out at 4°C. 
3.2.4.1 Protein extraction 
Cell pellets were thawed and resuspended in lysis buffer containing lysozyme, DNAse I 
and protease inhibitors. Different lysis buffers were used, depending on the construct to 
purify: Buffer L1 for histidine-tagged proteins, Buffer L2 for MBP-tagged proteins and 
Buffer L3 for co-expressed proteins (see Appendix 2 for the exact buffer composition). 
Cells were broken by incubation with lysozyme for 1 h under magnetic stirring, followed 
by sonication on ice. The lysate was clarified by centrifugation for 45 min at 25000 g and 
the supernatant was applied to the affinity column.  
In co-purification attempts cell pellets of different constructs were simply mixed and 
processed together as described above.   
3.2.4.2 Affinity chromatography 
Purification of Histidine-tagged proteins 
The soluble fraction was loaded on a Ni-HisTrap FF column (1 ml column volume (CV), 
GE Healthcare), previously equilibrated with 10 mM imidazole in Buffer A. Column was 
washed until a stable baseline was reached. Histidine-rich contaminants were eliminated 
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by washing with 10 CV of 50 mM imidazole. Bound proteins were finally eluted with 250 
mM imidazole in Buffer A.  
Purification of MBP-tagged proteins 
Supernatant was loaded on a MBPTrap HP column (1 ml CV, GE Healthcare) previously 
equilibrated with Buffer B. Column was extensively washed with buffer B to remove 
non-specifically bound proteins, and the protein of interest eluted with 10 mM maltose in 
Buffer B. 
Purification of co-expressed proteins 
A batch purification was performed by incubating the supernatant for 1 h with 500 µl of 
Ni-NTA Agarose resin, previously equilibrated with 10 mM imidazole in Buffer C. The 
resin was washed 3 times with increasing amounts of imidazole (10 mM, 50 mM and 
75 mM) to remove non-specifically bound proteins, and proteins were finally eluted with 
250 mM imidazole in Buffer C. 
3.2.4.3 Ion Exchange (IEx) chromatography 
Proteins eluted from the affinity chromatography column (except for complexes obtained 
by co-expression or co-purification) were diluted with Buffer IEx to decrease the 
concentration of NaCl down to 50-100 mM, and subsequently loaded on a HiTrap Q HP 
column (1 ml CV, GE Healthcare), previously equilibrated with 50 mM NaCl in Buffer 
IEx. Non-specifically bound proteins were washed away with the equilibration buffer. 
Bound protein was then eluted applying a 0.05-1  M NaCl  linear gradient in Buffer IEx, 
in 10 CV.  
IEx chromatography was not applied in the purification of complexes (obtained either by 
co-expression or by co-purification), as the salt present during the elution may disrupt the 
interaction among the Mcm subunits.   
3.2.4.4 Size exclusion chromatography (SEC) 
Proteins eluted from IEx chromatography were concentrated using Amicon Ultra 2 ml 
centrifugal filters (Millipore) with a molecular weight cut-off of 10 kDa.  Samples were 
centrifuged at 10000 g for 15 min to eliminate precipitate, and subsequently injected on a 
SEC Superdex 200 10/300 GL column (24 ml CV, GE Healthcare), previously 
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equilibrated with Buffer GF-A. Eluted proteins were analysed by SDS-PAGE, 
concentrated and stored at -80°C. 
3.2.4.5 Cleavage of SUMO-tag  
SUMO-tag was removed from AAA+ domains of Mcm2 and Mcm3 using the SUMO 
protease (Ulp1 from S. cerevisiae). This enzyme, differently from other proteases, 
recognizes the tertiary structure of SUMO rather than its amino acid sequence, cleaving in 
a highly specific manner. Proteins eluted from the affinity chromatography column were 
mixed with homemade SUMO-protease at a 1:500 ratio and digested overnight at 4°C. 
The protein cleavage was analysed by SDS-PAGE.   
3.3 Determination of protein parameters 
Theoretical values of molecular weight (MW), isoelectric point (pI) and extinction 
coefficient at 280 nm of all purified proteins, either individually or as a complex, were 
calculated from the amino acid sequences using the Protparam tool available at 
http://www.expasy.ch/tools/protparam.html.  
3.4 Determination of protein concentration and extent of DNA contamination 
Protein concentration was determined by measuring the absorbance at 280 nm with a 
Nanodrop apparatus (ThermoScientific) and using the theoretical extinction coefficients. 
DNA contamination of samples was evaluated by measuring the ratio between the 
absorbance at 260 and 280 nm; samples with a ratio < 0.7 are estimated to contain  less 
than 1% w/w of DNA (McPherson, 1999).  
3.5 Western Blot 
Western blot analysis was performed to confirm the presence of 6His-tagged proteins. 
After SDS-PAGE, samples were transferred from the acrylamide gel to a PDVF 
membrane using the iBlot
TM
 Gel Transfer Device (LifeTechnologies) for 7 min at 20 V. 
The membrane was incubated for 1 h in TPBS (PBS with 0.05% Tween) with 5% milk, 
washed three times with TPBS and incubated for 2 h with Anti-polyHistidine-Peroxidase 
antibody diluted in TPBS (1:2000) with 1% BSA. After three additional washes in TPBS, 
proteins were detected by exposing the membrane to the substrate of peroxidase (Sigma 
Aldrich). 
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3.6 Estimation of molecular weight from size exclusion chromatography 
The partition coefficient (KAV) of proteins in size exclusion chromatography empirically 
correlates with the Stokes radius, which can be used to predict the molecular weight 
(MW) of globular proteins with reasonable accuracy (Gell et al., 2012). The estimation of 
molecular weight by gel filtration can be made by comparing the KAV of the protein of 
interest with the KAV values obtained for several known calibration standards. The 
partition coefficient is related to the elution volume (Ve) as follows: 
𝐾𝑎𝑣 =
𝑉𝑒 − 𝑉0
𝑉𝑡 − 𝑉0
 
where V0 and Vt  are the void  and the bed volume of the column, respectively. 
Each gel filtration column was calibrated with the appropriated MW standards and Blue 
Dextran was used to determine the void volume. The KAV values were calculated for each 
standard and plotted against the corresponding logarithmic values of the molecular 
weight. Excel was used to calculate the regression line. The resulting calibration curve 
was used to calculate the unknown molecular weights from their KAV, which were 
obtained from their elution volume. 
3.7 Purification, characterization and crystallization of N-terminal domains  
3.7.1 Cloning and expression 
Fragments corresponding to N-terminal domains were previously cloned into Champion 
pET SUMO plasmid and pE-SUMOstar plasmid (LifeSensors). Each N-terminal domain 
was expressed in 250 ml of auto-inducing medium LB 5052 added with 10 µM of ZnSO4. 
Cells were grown for 4 h at 37°C, followed by over-night growth at 18°C. 
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Table 2.4: List of constructs for the expression of N-terminal domains.  
Name DNA insert Plasmid Resistance Tag Cleavability 
N2 
N-terminal 
domain of Mcm2 
(M1-N449) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
N3 
N-terminal 
domain of Mcm3 
(M1-D270) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
N4 
N-terminal 
domain of Mcm4 
(M1-D433) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
N5 
N-terminal 
domain of Mcm5 
(M1-S308) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
N6 
N-terminal 
domain of Mcm6 
(M1-P305) 
Champion 
pET SUMO 
Kanamycin 
6His-
SUMO 
Yes 
(SUMO-protease) 
N7 
N-terminal 
domain of Mcm7 
(M1-S309) 
pE-SUMOstar Ampicillin 
6His-
SUMO 
Yes 
(SUMO-protease) 
 
3.7.2 Co-purification 
Pellets of each construct were mixed and processed as previously described for the AAA+ 
domains. Supernatant was loaded on 10 ml HisTrap FF columns (2x 5ml CV, GE 
Healthcare), previously equilibrated with 10 mM imidazole in Buffer A. After a first 
wash with the equilibration buffer, bound proteins were washed with 10 mM imidazole + 
2 M NaCl in Buffer A in order to remove DNA contaminants. A further wash was 
performed with 50 mM imidazole in Buffer A to remove contaminants and decrease salt 
concentration. Proteins were finally eluted with 250 mM imidazole. 
Proteins were concentrated using an Amicon Ultra-15 centrifugal filter unit (Millipore) 
with a cut-off of 10 KDa. The elution buffer was changed with Buffer GF-N to remove 
imidazole and decrease the salt concentration.  
The sample was cleaved for 3 h with 1:100 SUMO-protease to remove the SUMO-tag 
and the cleavage product was analysed by SDS-PAGE. 
The sample was loaded on a HiLoad 16/60 or 26/60 Superdex 200 prep grade column 
(120 and 330 ml respectively, GE Healthcare), according to the amount of protein to 
purify and that was previously equilibrated with Buffer GF-N. Proteins eluted in different 
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chromatographic fractions were concentrated and injected again on the SEC column, in 
order to better separate species corresponding to different oligomeric states. Proteins were 
finally concentrated and stored at -80°C.  
Further analysis about the oligomeric state of the proteins was performed on Superdex 
200 10/300 GL and Superose 6 10/300 GL analytical columns (24 ml CV, GE Healtcare).     
3.7.3 Biophysical and biochemical characterisation 
3.7.3.1 Mass spectrometry 
Mass spectrometry was used to confirm the identity of the different Mcm subunits during 
the purification of the constructs corresponding to the Mcm N-terminal domains. Proteins 
eluted in the affinity chromatography step and digested with the SUMO-protease were 
separated by SDS-PAGE and stained with Coomassie Blue. Bands were excised from the 
gel and proteins were enzymatically digested and analysed with a MALDI-TOF mass 
spectrometer. The monoisotopic mass of the MALDI-TOF peaks was searched in the 
MASCOTT database and the hit with highest probability was considered. This analysis 
was performed by the Labratorio de Analises/Requimte at the Department of Chemistry 
of the University of Lisbon, Portugal.    
3.7.3.2 Native Polyacrylamide Gel Electrophoresis (Native PAGE) 
Native PAGE separates polypeptides based on the charge to mass ratio. Different 
oligomers of N-terminal domains, as eluted from size exclusion chromatography, were 
run on a Native PAGE gel to assess whether further separation could be achieved. 
Proteins were prepared in a non-reducing Native PAGE Sample Buffer, which maintains 
protein native secondary structure and charge density. Samples were loaded on a non-
denaturing 6% polyacrylamide gel and run for 2 h at 80 V in Tris-Glycine Buffer. 
Proteins were visualized by staining with InstantBlue. 
3.7.3.3 Thermal stability shift analysis 
Both the putative single and double hexamer formed by MCM N-terminal domains were 
tested for thermal stability in 61 different conditions. Samples were prepared in 
microplates (Biorad) as previously described by Boivin et al. (2013). Briefly, 25 µl were 
prepared for each condition by sequentially adding 16.8 µl of distilled water, 5 µl of 5X 
buffer, 1 µl of protein and 2 µl of 62X Sypro Orange solution (Invitrogen). Final 
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concentrations of the single and double hexamer complexes were 0.35 µM and 0.43 µM, 
respectively. The plate was sealed with an optical-clear tape (Biorad), centrifuged at 4°C 
at 2500 g for 30 s  to remove air bubbles and fluorescence intensity was measured  using 
a CFX96 Real-Time machine (Biorad). The Real Time-PCR machine was programmed as 
follows: 3 min of equilibration at 5°C to allow Sypro Orange diffusion, followed by a 
temperature gradient from 5 to 95°C, with 1°C increment every 0.1 min. Melting curves 
were processed with Bio-Rad CFX Manager 3.1 software.      
3.7.3.4 Circular Dichroism (CD) 
Sample preparation and data collection 
CD spectra of putative single and double hexamers formed by the N-terminal domains of 
MCM2-7 were collected with a Jasco-810 spectropolarimeter using a 0.1 cm quartz 
cuvette, in a wavelength range between  190 and 250 nm using two different buffers (Gel 
Buffer GF-N and Gel Buffer GF-N in which the NaCl concentration was lowered to 150 
mM). Protein concentration was determined by UV absorbance at 280 nm using the 
calculated ε value of 116330 M−1cm−1. Spectra were averaged from 3 scans of 0.1 nm 
steps at 20–50 nm/min. Due to the high NaCl absorbance at lower wavelengths, 
secondary structure analysis was restricted to the 200-250 nm range and performed using 
the Dichroweb tool K2D (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml). 
CD data analysis 
The K2D method is based on a type of neural network called SOM (Self Organizing 
Map), which is trained with CD spectra from proteins with known 3D structure. From the 
resulting map of spectra, "secondary structure maps" are derived. The secondary structure 
map is directly related to the spectra map and this relation is applied to estimate the 
percentages of content in alpha helix and beta strand of a protein from its CD spectrum 
(Andrade et al., 1993).  
The percentage values of secondary structure elements estimated from the CD spectra 
using K2D were compared with those from the secondary structure prediction based on 
the amino acid sequence performed with PSIPRED ( http://bioinf.cs.ucl.ac.uk/psipred/, 
Jones, 1999).The prediction was performed for each N-terminal domain monomer and the 
percentage of the different elements of secondary structure was calculated for the whole 
hexamer assuming the canonical 1:1:1:1:1:1 stoichiometry.    
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3.7.3.5 DNA binding studies with Fluorescence Polarization assay 
Preparation of DNA substrates 
Binding assays were performed using fluorescent probes. Oligonucleotides labelled with 
fluorescein at their 5’ end and their complementary strands were purchased by 
Sigma-Genosys (Table 3.5). Double stranded and fork DNA were prepared as follows: 
equal amounts of complementary oligonucleotides were annealed in the Annealing Buffer 
(see Appendix 2 for the exact composition), by heating for 5 min at 100°C followed by 
slow cooling at 25°C.   
Table 2.5: List of oligonucleotides used for DNA binding assays.  
Name   Sequence (5' to 3') 
Fork22tF [Flc]-GTAGTGCATGTACACCACACTCTTTTTTTTTTTTTTT 
Fork22b TTTTTTTTTTTTTTTGAGTGTGGTGTACATGCACTAC 
Blunt22tF [Flc]-GTAGTGCATGTACACCACACTC 
Blunt22b GAGTGTGGTGTACATGCACTAC 
 
Sample preparation for binding reaction 
Triplicate samples for fluorescent polarization measurements were prepared as previously 
described by Moerke (2009), with little modifications. Aliquots of 180 µl of protein 
stored at -80°C were thawed and centrifuged for 15min at 10000 g to remove precipitates. 
Series of 8 two-fold dilutions were prepared by sequentially diluting 90 µl of protein 
solution with 90 µl of Buffer GF-N. The same volume of labelled DNA was added to 
each sample from 1 µM stock solution, to a final concentration ranging between 1 and 10 
nM. Samples were carefully mixed by pipetting and incubated at 23°C for 30 min with 
gentle agitation. Triplicates were also prepared for the no-protein solution and for the 
buffer alone, which was used to measure background fluorescence. 
Fluorescence polarization measurements 
Fluorescence polarization was measured with a Tecan Infinite 200Pro plate reader 
equipped with filters for excitation and  emission wavelengths at 485 and 535 nm, 
respectively. The instrument automatically subtracts the background fluorescence value 
from each sample measurement and subtracted values are output in milliunits of 
polarization (mP). 
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Data analysis 
Data were analysed using GraphPad Prism 5. The averaged polarization of the three 
samples for each protein dilution was plotted against the corresponding protein 
concentration. Nonlinear regression analysis was performed by fitting the data to the 1:1 
binding model (Equation 1) and the Hill equation (Equation 2), described as follows: 
Equation 1 
𝑌 = 𝐵𝑚𝑎𝑥 ×
𝑋
𝐾𝑑 + 𝑋
+ 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 
Equation 2 
𝑌 = 𝐵𝑚𝑎𝑥 ×
𝑋ℎ
𝐾𝑑
ℎ + 𝑋ℎ
+ 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑 
where Y is the averaged fluorescence polarization at the protein concentration X, Bmax is 
the value of polarization at saturation, Kd the apparent binding constant and h is the Hill 
cofficient, which depends on the cooperativity of binding and number of interacting sites 
(Goutelle et al., 2008; Weiss, 1997). The term “Background” refers to the measured 
polarization with no added protein, and is defined as (Ymax-Ymin)/(Xmax-Xmin).  
3.7.3.6 Electrophoretic mobility shift assay (EMSA) 
Protein-DNA complexes were detected by a gel mobility shift assay, using fluorescence-
based detection. 20 µl of each sample previously analysed by fluorescence polarization 
assay were electrophoresed for 1.5 h at 80V through a 6% polyacrylamide gel in 0.5X 
TBE. 5% glycerol present in the reaction buffer ensured the proper loading of the samples 
without addition of any loading buffer, which could possibly have a destabilizing effect 
on the complex. Fluorescent DNA was visualised with ImageQuant LAS 4000 (GE 
Healthcare), equipped with the proper lamp and filter. 
3.7.3.7 Multi angle light scattering (MALS)  
MALS analysis was conducted on single and double hexamer in collaboration with the 
group of Dr. Rambo at Diamond Light Source. A DAWN detector (Wyatt Technology) 
was used, coupled to a SEC column KW 404 (Shodex) connected to an Agilent HPLC 
system (Agilent Technologies). The instruments and the attached column were 
equilibrated with buffer prior to run. Two different buffers were used for the analysis: 
55 
 
Buffer GF-N and SAXS experimental buffer (20 mM Hepes pH 7.5, 25 mM KH2PO4, 
50mM NaCl, 100 mM KCl, 0.5% (w/v) sucrose). 50 μL of sample were concentrated up 
to 4mg/ml and injected into the system for analysis. The elution profiles of the 
experiments were collected as UV-absorbance (280nm) spectra and intensity of scattering 
at 17 different angles. The ASTRA™ software (Wyatt Technology) was used to assign 
the molecular mass averages. 
3.7.3.8 Small angle X-ray scattering (SAXS) data collection and analysis  
Solution scattering data of the double hexamer were collected at the B21 SAXS beamline 
of the Diamond Light Source, under the supervision of Dr. Robert Rambo, the beamline 
scientist responsible for the shifts. 50 µl of sample were concentrated up to 4 mg/ml and 
injected onto the SEC column KW 404, previously equilibrated with the SAXS 
experimental buffer: 20 mM Hepes pH 7.5, 25 mM KH2PO4, 50 mM NaCl, 100 mM KCl, 
0.5% (w/v) sucrose. The gel filtration run and the data collection were performed at 4°C. 
The fractions containing the protein were analysed using the equilibration buffer as 
reference.  
Data collection was performed at 12.4 keV with a Pilatus 2M detector at 3.9 meter of 
distance, in order to collect data with a momentum transfer (q=4πsinθ/λ) with a range of 
q-value from 0,015 to 0.3 Å
-1
. 42 images were collected with the automatized ESRF 
BioSAXS Robot, by exposing the sample 10sec/image. All the calibration and 
normalization processes were automatically performed on the beamline using the in-
house software package. The scattering contribution of the buffer was subtracted from the 
total scattering of the protein sample using Primus, part of the ATSAS suite (Petoukhov 
et al., 2012).  
Different models for N-terminal single and double hexamer were built from available X-
ray structures or EM models, as listed in Table 3.6, using Chimera (Pettersen et al., 2004), 
Coot (Emsley et al., 2010) and PyMol (SchrödingerLLC) software. Hypothetical 
scattering curves were generated from these models using CRYSOL (Svergun et al., 
1995), and subsequently compared to the experimental scattering curve; the discrepancy 
factor χ2 was used to estimate the quality of the fits between experimental and calculated 
scattering curves. 
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Table 2.6: Models of MCM proteins. 
X-ray structure 
MthMCM (PDB: 1LTL, Fletcher et al., 2003) 
SsoMCM (PDB: 2VL6, Liu et al., 2008) 
TacMCM (PDB: 4ME3, Fu et al., 2014) 
PfuMCM (PDB: 4POF, Froelich et al., 2014) 
EM model 
S. cerevisiae (EMD: 5857, Sun et al., 2014) 
 
3.7.4 Protein crystallization  
3.7.4.1 Crystallization screens 
In order to identify crystallization conditions, proteins were initially screened using the 
sitting-drop vapour diffusion method with the following 96 condition sparse matrix 
screens: Index (Hampton Research), Wizard I + II (Emerald BioSystems) and Morpheus 
(Molecular Dimensions). Different incubation temperatures and different protein stock 
concentrations were tested, as summarized in Table 3.7. For each well, 80 µl of 
crystallisation solution was dispensed using a Matrix Hydra II robot (Thermo Scientific). 
Protein stock solutions were defrosted and centrifuged before being dispensed using a 
Mosquito pipetting robot (TTP Labtech). 0.1 µl of protein were mixed with 0.1 µl of the 
mother liquor in MRC crystallisation trays. Trays were sealed manually using transparent 
tape and stored at 4°C or 20° C. 
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Table 2.7: Summary of crystallization trials in 96 well sparse matrix. 
Double Hexamer 
Protein concentration  Matrix  Temperature 
3 mg/ml Index 20°C 
3-4 mg/ml Morpheus 20°C 
3-4 mg/ml Wizard I + II 20°C 
4 mg/ml Morpheus 4°C 
4 mg/ml Wizard I + II 4°C 
Single Hexamer 
Protein concentration  Matrix Temperature 
4.1 mg/ml Morpheus 20°C 
4.1 mg/ml Wizard I + II 20°C 
 
3.7.4.2 Optimization 
Single crystallization hits were optimized in 24 well Linbro plates (Hampton Research) 
using the hanging-drop vapour diffusion method. Different concentrations of the major 
precipitant and additives were tested. The major precipitant was screened with a gradient 
spanning from 80% to 110% of the original concentration found in the hit. Additives were 
tested at concentrations corresponding to 0.1, 0.5, 1.0 and 1.5 multiples of the hit 
concentration. Droplets, consisting of 1 µl of protein and 1 µl of reservoir solution, were 
equilibrated against 1ml of reservoir at 20°C.        
Microseeding 
Seed stocks were prepared by mechanical homogenization of crystals as described by 
Luft and DeTitta (1999). Crystals were diluted in 50 µl of reservoir solution, broken and 
vortexed for 3 min with the Seed Bead Kit (Hampton Research). Seed stock solutions 
were stored at -80°C. 
Serial dilutions of seeds in a 10
-3
-10
-7
 range were used to optimize crystal growth. The 
sitting-drop vapour diffusion condition was reproduced in 24 well Linbro plates using 
Micro-Bridges (Hampton Research). Droplets consisting of 0.5 µl of seeds, 1 µl of 
reservoir and 1µl of protein were equilibrated against 500 µl of reservoir solution at 20°C.  
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4 RESULTS AND DISCUSSION 
The eukaryotic MCM2-7 helicase is a six-subunit enzyme that plays a key role during 
DNA replication by providing a single stranded template for the DNA polymerase, and it 
is the target of several mechanisms of regulation (Bell and Botchan, 2013; Bell and 
Kaguni, 2013; Tanaka and Araki, 2013). Consistent with their major role in this process, 
MCM2-7 proteins are overexpressed in several tumours and mutations in these proteins 
are associated to genomic instability and cancer development (Bagley et al., 2012; 
Giaginis et al., 2010; Kawabata et al., 2011). Thus, they have been recently proposed as 
new targets for cancer treatment (Simon and Schwacha, 2014). The availability of a high 
resolution structure of the human MCM2-7 complex would help the design of specific 
inhibitors, but the structural complexity of this enzyme makes it a difficult target for 
crystallographic studies.  
Several attempts have been done in different laboratories to reconstitute the eukaryotic 
MCM2-7 complex, either by refolding of the insoluble subunits expressed in bacteria, or 
by expressing them in baculovirus systems. These methods provided sufficient protein 
quantities for biochemical studies, but they were unsuccessful in reaching the quantity 
and purity necessary for crystallographic studies.  
The expression and purification of individual functional domains of a protein is a useful 
strategy to obtain homogeneous samples suitable for crystallisation. In the case of MCM 
proteins, the availability of sufficient amounts of recombinant subunit fragments would 
also allow a detailed biophysical analysis of intra-molecular interactions as well as 
interactions with DNA and other partner proteins. Therefore, based on bioinformatics 
analysis and structural information from archaeal MCM proteins (see Appendix 1), we 
designed fragments corresponding to the AAA+ domains and the N-terminal domains of 
human MCM2-7 proteins, which were cloned into vectors suitable for expression in 
E. coli.   
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Figure 2.2: Human Mcm proteins. A schematic representation of the primary structures of the 
human Mcm proteins, compared to the canonical archaeal sequence (upper part), is here 
reported. The three domains are shown in different colours: Green: N-terminal, Orange: AAA+, 
Blue: C-terminal domain. Start and end point of each cloned fragment are reported in the right 
panel.    
The results of this PhD project are discussed in this chapter. The chapter is organized into 
two different sections: the first part describes the cloning, expression and purification of 
the AAA+ domains, either as single constructs or as a complex; the second part describes 
the protocol for purification of the N-terminal domains, and reports the biophysical 
characterization and crystallization trials of N-terminal domains in different oligomeric 
states.   
4.1 Part I: the AAA+ domains 
4.1.1 Cloning, expression and purification of individual constructs 
To increase the chance to obtain soluble proteins, we decided to clone the AAA+ domain 
sequences of human MCM2-7 fused with a 6His-SUMO tag. This small ubiquitin-like 
protein has been shown to increase the level of expression and solubility of difficult-to- 
express proteins (Marblestone et al., 2006). The use of the SUMO tag also provides 
another important advantage as it is possible to remove the tag from the recombinant 
protein using the SUMO-protease Ulp1. This enzyme recognises the tertiary structure of 
SUMO and does not require the insertion of any specific sequence for the cleavage. Thus, 
it eliminates the tag without leaving any extra residues.    
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The sequences of AAA+ domains of Mcm2-6 were successfully cloned into the 
Champion pET SUMO/CAT vector by Restriction Free (RF) cloning (Unger et al., 2010), 
by replacing the DNA sequence of the Chloramphenicol-Acetyl-Transferase (Figure 4.2). 
 
Figure 2.3: Cloning of AAA+ domains. (A) RF cloning procedure (adapted from Erijman et al., 
2011). (B) Example of positive clones for construct A2 (1074 bp), identified by PCR colony 
screening; the black arrow indicate the reference band (1000 bp). 
Despite the efforts and the screening of several different parameters (e.g. annealing 
temperature or DMSO concentration) proper PCR conditions for the generation of the 
megaprimers of the AAA+ domain of Mcm7 could not be obtained. As the RF strategy is 
based on the design of primers which overlap to both the target sequence and the 
destination vector, it is possible that the primers designed for RF cloning in the pET 
SUMO/CAT plasmid may generate secondary structures or primer dimers that impaired 
the amplification of the target sequence.  
A B 
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The Mcm7 AAA+ sequence was therefore cloned with the In-Fusion technology. This 
technique requires the amplification of the DNA insert with primers that have 15-base 
extensions complementary to the ends of the linearized cloning vector. The resulting PCR 
product is subsequently incubated with the linearized vector and the In-Fusion enzyme. 
This enzyme creates single-stranded DNA regions at the ends of the vector and the PCR 
product, which are then fused due to the complementarity of the overhanging strands 
(Figure 4.3). 
 
Figure 2.4: In-Fusion cloning (adapted from Clontech Laboratories, 2014). A schematic 
diagram illustrating the In-fusion strategy. See text for details. 
This technique allowed to successfully clone the sequence of interest into four plasmids 
of the pOPIN vector suite (produced by the OPPF-UK), a family of expression vectors 
characterised by the presence of different promoters that allow their simultaneous use in 
different expression systems (bacterial, insect and mammalian cells). A list of the 
constructs resulting from the cloning procedure and used for the expression trials is 
provided in Table 4.1. 
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Table 2.8: Summary of constructs of AAA+ domains. N-terminal and C-terminal residues are 
specified for each protein fragment, together with the tag and the corresponding molecular 
weight (with and without the tag). Construct A7-E is non-cleavable. 
Name Residues Tag Mw (+tag) Mw (-tag) 
A2 V451-S809 (Mcm2) 6His-SUMO 53 kDa 39.6 Kda 
A3 A272-K660 (Mcm3) 6His-SUMO 56.6 kDa 43.2 kDa 
A4 A436-P776 (Mcm4) 6His-SUMO 51.7 kDa 38.3 kDa 
A5 G305-G655 (Mcm5) 6His-SUMO 51.7 kDa 38.3 kDa 
A6 T321-D663 (Mcm6)  6His-SUMO 52 kDa 38.6 kDa 
A7-F S309-D647 (Mcm7) 6His 39.8 kDa 37.8 kDa 
A7-M S309-D647 (Mcm7) 6His-MBP 80.4 kDa 37.8 kDa 
A7-C S309-D647 (Mcm7) 6His-SUMO 50.8 kDa 37.8 kDa 
A7-E S309-D647 (Mcm7) 6-His (C-term) 38.7 kDa / 
 
The constructs of the AAA+ domains were transformed into different strains of E. coli 
cells (including BL21 pLysS, BL21 codon plus RIPL, Arctic RP, Rosetta2 pLysS) and 
expressed exploring different conditions, testing different temperatures, growth media 
(LB or TB), expression times and induction methods (autoinduction or IPTG, ranging 
from 0.1 to 1 mM), as previously summarised in Table 3.3 of Materials and Methods.   
Expression in Rosetta2 pLysS strain in TB by over-night induction with 0.1 mM IPTG at 
17°C proved to be the optimal condition to obtain soluble protein for all the fragments 
fused with the 6His-SUMO tag (Figure 4.3, A and B). The same protocol worked 
successfully also for the constructs of the AAA+ domain of Mcm7, except for the one 
bearing a 6His-tag at the C-terminus. The best results were achieved using the MBP-tag, 
therefore the construct cloned into the pOPINM vector was chosen for the scaled-up 
purification (a couple of examples of purifications are shown in Figure 4.3, C and D).  
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Figure 2.5: Small scale expression tests. (A) Small scale expression of construct A2: the band 
corresponding to the soluble protein (53 kDa) is indicated by the red arrow. TE: total extract, 
SOL: soluble fraction, FT: flow-through, W1: first wash, W2: second wash, ELU: elution. (B) 
Western blot with anti-His antibody performed on the elution fractions for each construct from A2 
to A6. (C) Small scale expression and (D) western blot of protein expressed from construct A7-M 
(80.4 kDa, green arrow). 
The general strategy applied to purify each AAA+ domain separately is illustrated in 
Figure 4.5: a first affinity chromatography step (HisTrap or MBPTrap, depending on the 
fusion tag of the construct), followed by an ion exchange (IEx) chromatography step to 
remove contaminants, and a final size exclusion chromatography (SEC) step to achieve 
high purity and to separate possible species corresponding to different oligomeric states. 
A detailed description of the results obtained from each purification step is reported for 
the AAA+ domain of Mcm2 (construct A2) as an example. The same or a similar 
purification protocol was applied to all recombinant AAA+ domains.  
A B 
C D 
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Figure 2.6: Purification strategy for AAA+ domains. See text for details. 
The protein eluted from the affinity chromatography column was treated with the 
SUMO-protease Ulp1 to remove the fusion tag. Both the protease and the tag are 
separated from the protein of interest in the following purification steps. Initial cleavage 
trials carried out on A2 and A3 revealed that these subunits are not soluble in the absence 
of the SUMO tag (Figure 4.6, B). Thus, we decided to reconstitute the complex with  
purified subunits still bearing the fusion tag. In fact, tags can be removed subsequently 
after complex formation.  
 
Figure 2.7: Affinity chromatography for construct A2. (A) Fractions of the first purification 
steps, from protein extraction to elution from the affinity column; the protein of interest (A2) is 
indicated by the red arrow. (B) Comparison of A2 before and after the tag removal. The protein 
precipitated after the SUMO cleavage. 1: sample before the treatment, 2: sample after the 
treatment, 3: sample after centrifugation (10000 g for 10 min).   
A B 
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A IEx chromatography step was introduced in order to increase the purity of the 
recombinant proteins. The anion exchange HiTrap Q HP column was used and a linear 
gradient of NaCl was applied to elute the proteins. This column allowed a full separation 
of the proteins from DNA contaminants.  
 
Figure 2.8: IEx chromatography for A2. (A) The sample is mainly eluted in Peak 1; Peak 2 
represents the protein fraction bound to DNA and therefore eluted with higher salt concentration. 
The green line represents the linear gradient applied for the elution. (B) SDS-PAGE of fractions 
from the different eluted peaks. A2 is highlighted by the red arrow.  
SEC was applied as the last purification step. As shown in Figure  4.8, the AAA+ domain 
of Mcm2 was eluted into three different peaks. Peak 1 fractions correspond to the column 
void volume and thus contain large aggregates or protein bound to DNA fragments. 
Fractions corresponding to Peak 2 are characterized by the presence of a contaminant, 
most probably DnaK, a 70 kDa E.coli chaperon that usually binds to fully or partially 
unfolded proteins (Schönfeld et al., 1995; Schröder et al., 1993). Most of the target 
protein is eluted in Peak 3 and the corresponding molecular weight (estimated from the 
elution volume as described in the Material and Methods chapter) of ~100 kDa is 
compatible with a dimer of A2. A lower MW band suggests the presence of limited 
proteolysis. 
A similar behaviour was also observed for A3 but not for the other subunits, which 
mostly precipitated or aggregated during the SEC elution, as described in Table 4.2. The 
high instability of these subunits prevented the assembly of the full complex. Poor 
solubility of AAA+ domains has also been reported by others for Mcm4, 6 and 7 from 
Schizosaccaromices pombe, showing that all constructs containing a complete or 
truncated AAA+ domain precipitate or aggregate when expressed separately (Xu et al., 
2013). A number of variations to the purification protocols were tested, in order to 
A B 
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optimise the situation, but none provided robust and reproducible improvements. 
Therefore, a different approach was required.   
 
 
Figure 2.9: Size exclusion chromatography for A2. (A) Elution profile. Molecular weights 
corresponding to the elution volumes were calculated as previously indicated in Materials and 
Methods; Mw standards are marked with black arrows. Fer: ferritin (440 kDa); Ald: aldolase 
(158 kDa); Con: conalbumin (75 kDa). (B) SDS-PAGE of fractions corresponding to the different 
elution peaks. Violet arrow: DnaK, Red arrow: A2.  
Table 2.9 Summary of purification results for independently expressed AAA+ domains. 
Construct Expression 
Purification 
Affinity Ion Exchange Size Exclusion Tag Cleavage 
A2 V V V V precipitates 
A3 V V V V precipitates 
A4 V V V precipitates  
A5 V V V precipitates  
A6 V V V precipitates  
A7-M V V V aggregates  
 
4.1.2 Co-expression and Co-purification of AAA+ domains 
The co-expression or co-purification of interacting proteins or protein domains forming a 
complex have been often reported to provide a successful strategy to increase the 
complex solubility and stability (Perrakis and Romier, 2008). A similar approach was 
pursued here and co-purification of the AAA+ domains was first attempted by mixing the 
pellets originated from different cell cultures. However, one of the draw-backs of this 
A B 
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procedure is that all MCM subunits have very similar molecular weights, and it is 
therefore difficult to separate and detect them by SDS-PAGE during purification. The 
only exception is the AAA+ domain of MBP-Mcm7, which has a molecular weight much 
larger than those of the other subunits. Our co-purification attempt was therefore limited 
to the AAA+ domains of Mcm4, 6 and 7, also because purification and reconstitution of a 
functional MCM4/6/7 hexamer have been previously reported in the literature (Ishimi, 
1997; Xu et al., 2013; You et al., 1999, 2002).  
Co-purification was performed as described in Materials and Methods: the three 
constructs were expressed separately and cell pellets were subsequently mixed and lysed 
together. Affinity chromatography was performed using a MBPTrap HP column with the 
aim to capture the AAA+ domain of Mcm7 (A7-M) bound to stoichiometric amounts of 
the other two interacting subunits. However, this approach did not give the expected 
results, as only A7-M was detected by SDS-PAGE. The failure of this approach could be 
due to two main reasons: (i) the interaction among the AAA+ domains is labile, as also 
suggested by EM models (Costa et al., 2011), or (ii) the proteins are not properly folded 
and cannot form a complex. 
In a co-expression procedure, the simultaneous presence of the interacting partners 
forming a complex may increase the partners’ solubility and help obtain a properly folded 
and functional complex (Romier et al., 2006; Tolia and Joshua-Tor, 2006). In our case, 
the co-expression of the six AAA+ domains could be achieved through the generation of 
two polycistronic constructs, by sequential cloning of the target sequences of Mcm7, 4 
and 6 in the pACYC Duet-1 vector, and of the sequences of Mcm3, 5 and 2 in the pET 
Duet-1 vector (Figure 4.9).  
 
Figure 2.10: New cloning strategy for co-expression of Mcm subunits. For details regarding 
the cloning procedure and generation of polycistronic constructs refer to Paragraph 3.2.1.4 of 
Materials and Methods.  
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Small scale expression tests were performed for these constructs, after separate or 
combined transformation in different E. coli cell strains. Soluble protein was detected via 
co-transformation of the two plasmids in BL21 pLysS cells and induction with 0.3 mM 
IPTG for 4 h at 25°C. Large scale preparation was performed in a similar way as for 
individual AAA+ domains. Lower NaCl concentration was used in the purification 
protocol, since high ionic strength could disrupt the interactions between the subunits. Ion 
exchange chromatography was in this case avoided for the same reason. Finally, in a 
further attempt to stabilise the complex, a non-hydrolysable ATP analogue (ADP•AlF3) 
was added to the lysis buffer.  
Size exclusion chromatography showed that most of the sample eluted with a molecular 
size compatible with a dimer of Mcm (Figure 4.10). Western blot with anti-His antibody, 
performed on the fractions corresponding to the elution peak, revealed the presence of 
two bands which could be identified as Mcm3 and 7. Identification of the other bands that 
are visible on the SDS-PAGE gel was not possible. The use of commercially available 
antibodies against the full-length proteins did not produce a clear-cut result, as the AAA+ 
domain is the most conserved among the different paralogues; this high sequence 
similarity can possibly lead to cross-reactions. The small amount of protein obtained did 
not allow to perform additional analyses for identification.  
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Figure 2.11: Purification of co-expressed AAA+ domains. (A) Fractions eluted from the 
affinity column. Some protein was detected in the elution with 250 and 500 mM imidazole (red 
box). (B) Elution profile from size exclusion chromatography. Much of the protein showed an 
elution volume compatible with a dimer (peak 2). (C) SDS-PAGE with fractions corresponding to 
the different elution peaks. N: sample eluted from affinity chromatography but not injected onto 
SEC column; 1,2,3: samples from fraction in peaks 1, 2, and 3 of chromatogram B. (D) Western 
blot with anti-His antibody performed on fraction 2. Two bands have been identified, possibly 
corresponding to the AAA+ domains of Mcm7 (upper band) and Mcm3 (lower band). 
A B 
C D 
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The results obtained by co-expression further suggest that the AAA+ domains are not 
able to form a stable complex in the absence of stabilizing factors. It is reasonable to 
assume that the N-terminal domains are required to guarantee the assembly of the AAA+ 
domains in the MCM ring, which is necessary to reconstitute the ATPase active sites. In 
fact, the N-terminal domains have been shown to be critical for the assembly of the 
archaeal MCM complex (Fletcher et al., 2003; Kasiviswanathan et al., 2004); moreover, 
EM models show that the N-terminal domains form a more compact ring, while the 
AAA+ domains show higher flexibility, even in presence of a non-hydrolysable ATP 
analogue (Costa et al., 2011, 2014). 
In summary, the AAA+ domains of human MCM2-7 showed high instability in all 
purification attempts using the E. coli expression system, preventing any further structural 
or biochemical study. 
4.2 Part II: the N-terminal domains 
4.2.1 N-terminal domains assemble into different oligomers 
Cloning of N-terminal domains into the pET SUMO/CAT vector with the RF cloning 
method, small scale expression tests and initial purification trials have been previously 
carried out in our laboratory. N-terminal fragments exhibited high levels of expression 
and solubility and recombinant protein production was easily scaled up with a protocol 
similar to the one adopted for the AAA+ domains. However, tag removal showed to be a 
critical step in this case: the SUMO protein always co-eluted with the protein after the tag 
cleavage, despite the efforts to remove it with several purification steps (Figure 4.11). 
Moreover, our attempts to reconstitute a hexameric complex from the purified fragments 
were unsuccessful. As described below, this problem was overcome by co-purification of 
the fragments.  
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Figure 2.12: Example of individually purified N-terminal domains. The constructs of interest 
are indicated by green stars, SUMO by a red arrow.  
Table 2.10 List of expressed constructs of N-terminal domains.  
Name Residues Tag Mw (+tag) Mw (-tag) 
N2 M1-N449 (Mcm2) 6His-SUMO 64 kDa 51 kDa 
N3  M1-D270 (Mcm3) 6His-SUMO 44 kDa 31 kDa 
N4 M1-D433 (Mcm4) 6His-SUMO 61.7 kDa 48.7 kDa 
N5 M1-S308 (Mcm5) 6His-SUMO 48 kDa 35 kDa 
N6 M1-P305 (Mcm6) 6His-SUMO 48 kDa 35 kDa 
N7 M1-S309 (Mcm7) 6His-SUMO 49 kDa 36 kDa 
 
Pellets from equal amounts of culture medium expressing each construct were mixed and 
lysed together. Affinity chromatography was performed as for the AAA+ domains. An 
additional washing step with 2 M NaCl was introduced to remove DNA contaminants, 
leading also to the elution of large amounts of proteins (Figure 4.12, A and B). It is 
possible that part of the proteins do not bind directly to the resin through the Histidine-
tag, but are retained by the interaction with other subunits. This interaction may be 
disrupted by the high ionic strength, justifying the leakage during the washing step.   
Samples were concentrated using filters with the appropriate cut-off and the elution buffer 
was replaced with Buffer GF-N (see Appendix 2) to remove the imidazole and reduce the 
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salt concentration, thus providing the optimal conditions for the treatment with 
SUMO-protease.  Four of the six subunits (N3, 5, 6 and 7) showed very similar mobility 
in SDS-PAGE gels, consistent with their similar molecular weights (Figure 4.12, C). 
Interestingly, the N2 band shows a gel mobility corresponding to an apparent molecular 
weight higher than expected. Mass spectrometry performed on individual bands excised 
from the gel, however, confirmed the expected molecular weight for all subunits.  
 
Figure 2.13: Co-purification of N-terminal domains. (A) Profile showing elution at different 
gradient steps of the affinity chromatographic purification. (B) SDS-PAGE of fractions from the 
Peaks 1 and 2 of the previous chromatogram. Most protein elutes during washing with 2 M NaCl 
(Peak 1). (C) Cleavage of SUMO tag. SP: SUMO-protease, 1: sample before tag removal, 2: 
sample after tag removal, 3: sample after centrifugation.    
Size exclusion chromatography was performed on the samples after protease treatment to 
characterize the oligomeric state of the proteins. This purification step also allowed to 
A 
B C 
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remove the protease as well as the fusion tag. Different assemblies were present either in 
the sample eluted with 2 M NaCl and in the sample eluted with 250 mM imidazole, as 
shown by the elution profiles with multiple peaks (Figure 4.13). In particular, both 
samples show a peak with an elution volume compatible with a double hexameric 
complex. Conversely, only the sample eluted with 2 M salt shows a peak compatible with 
a single hexameric complex. Further elution peaks, corresponding to lower molecular 
weights, are compatible with a mixture of different smaller oligomers (dimers and 
trimers) as well as monomers.  
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Figure 2.14: Size exclusion chromatography. (A) Overlapping gel filtration profiles obtained 
from proteins eluted from affinity chromatography: the red curve correspond to Peak 1 of 
Fig. 4.11 and represents the protein eluted during the 2 M wash, whereas the blue curve 
represents the protein from Peak 2, eluted at 250 mM imidazole. Putative single (237 kDa) and 
double hexamers (474 kDa) are highlighted in magenta and cyan, respectively. Letters from a to 
h indicate different peaks of the red curve. Thr: thyroglobulin (669 kDa), Fer: ferritin (440 kDa), 
Alch: alcohol dehydrogenase (150 kDa). (B) SDS-PAGE of fractions corresponding to the 
different elution peaks (from a to h) of the sample eluted during high salt wash (red curve of the 
upper figure). Each protein is shown with a different colour: Cyan: N2, Yellow: N4, Orange: N5, 
Magenta: N7, Blue: N3, Green: N6. SUMO is indicated by a red arrow.   
A 
B 
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To enhance separation, a second SEC chromatography step was applied to both samples 
(Figure 4.14). The SDS-PAGE analysis showed that both the putative single and double 
hexamers contain all six subunits, although their relative amounts are not compatible with 
the expected 1:1:1:1:1:1 stoichiometry; this observation may be explained with a different 
staining of the subunits using Comassie Blue dye. Putative single and double hexamers 
behaved differently on Native PAGE gels, confirming that they are indeed two different 
species (Figure 4.14, C). However, the presence of multiple bands from the single 
hexamer sample suggests either a reduced stability of this complex, which may separate 
into different sub-complexes, or the presence of multiple hexamers with a different 
subunit composition (for example, a mixture of MCM2-7 and MCM4/6/7).  
 
Figure 2.15: Finale size exclusion chromatography. (A) Elution profile of putative single (SH, 
magenta curve) and double hexamer (DH, cyan curve) from Superose 6. (B) SDS-PAGE with 
different chromatographic fractions corresponding to the peaks of single and double hexamer. 
Band corresponding to the different polypeptides are highlighted with different colours. Cyan: 
A 
B C 
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N2, Yellow: N4, Orange: N5, Magenta: N7, Blue: N3, Green: N6. (C) Native PAGE of the two 
assemblies. 
Up to now, recombinant full-length Mcm proteins expressed in eukaryotic systems have 
always been purified as a single hexamer (Hesketh et al., 2015; Ilves et al., 2010; Kang et 
al., 2012; Xu et al., 2013); however, in our hands, human homologues of the Mcm 
N-terminal domains recombinantly expressed in E. coli assemble into a stable double 
hexamer. This different behaviour could be ascribed to the different 
expression/purification protocols, and/or to the lack of post-translational modifications in 
the E. coli system. In order to better characterize the properties of the two MCM 
complexes produced in this work, further biophysical and biochemical analysis were 
carried out.        
4.2.2 Biophysical and biochemical characterization of the putative single and 
double MCM hexamers 
4.2.2.1 Thermal shift analysis 
Purification trials revealed that samples of both putative single and double hexamers were 
not able to reach concentrations higher than 4-5 mg/ml in the buffer used (Buffer GF-N: 
30 mM Tris pH 7.9 (at 4°C), 250 mM NaCl, 5% Glycerol, 2 mM β-mercaptoethanol). 
Moreover, numerous attempts to change Buffer GF-N with other buffers more suitable for 
crystallization trials (e.g. by reducing the NaCl concentration or by substituting Tris with 
Hepes) always resulted in severe protein precipitation. Thermal shift analysis, also named 
Thermofluor Assay, which simultaneously screens many different conditions using small 
amounts of sample, was therefore performed to identify a condition which could improve 
the stability of the complex and help purify, concentrate and crystallize the target 
proteins.  
The basic principle of Thermofluor is described in Figure 4.15 (Boivin et al., 2013): a 
protein solution is mixed with a hydrophobic dye, whose fluorescence is quenched in the 
aqueous environment; as the mixture is heated up, the dye regains its fluorescence by 
binding the protein hydrophobic moieties exposed by protein unfolding. Fluorescence 
values are plotted against the temperature values and the resulting curve allows to 
estimate the melting temperature (Tm). Values obtained in different buffers are compared 
and positive shifts are associated to an increase in structural order. Multi-phase melting 
curves are usually observed for proteins containing independent domains or for protein 
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complexes, as the different domains or subunits may show different behaviours during the 
denaturation process. 
 
Figure 2.16: Principles of Thermofluor (modified from Boivin et al., 2013). (A) Fluorescence 
intensity is a direct measure of the fraction of unfolded protein, as the dye emits the fluorescent 
signal only after binding the hydrophobic core of the protein that is exposed by denaturation. 
Maximal fluorescence is obtained when the protein is completely unfolded. The signal decreases 
after dye-protein dissociation. (B) Melting temperature corresponds to the inflection point of the 
melting curve. Curves obtained in different conditions are compared to search for positive ΔTm.    
From the screening used by Boivin et al. (2013), we selected 23 different buffers to cover 
a pH range from 4.0 to 9.5, and these were tested in the presence and absence of 250 mM 
NaCl (Figure 4.16). Since one of our aims was to find optimal conditions for 
crystallization, we avoided phosphate buffers, as they often form insoluble salts with 
many cations present in crystallization screens. At physiological pH (7.5), three different 
concentrations of both Tris and Hepes were tested (10/50/100 mM), as well as three 
different concentrations of NaCl (150/250/500 mM). Melting curves obtained in various 
conditions were compared with the melting curve recorded with Buffer GF-N (without β-
mercaptoethanol).   
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Figure 2.17: Panel of conditions for Thermofluor. 23 different buffers, at a final concentration 
of 50 mM, were tested with (dark blue) or without (light blue) 250 mM NaCl. Three different 
concentrations of Hepes (pink) and Tris (light green) were also tested. A screening with three 
different salt concentrations was also performed with 50 mM Hepes (violet) and Tris (dark 
green). pH values of Tris buffers are show at room temperature. Buffer GF-N is represented in 
positions A7 and H7 of the panel.  
To choose the best buffer conditions we evaluated two different parameters: the Tm and 
the shape of the melting curve (Figure 4.17). As both single and double hexamers are 
formed by different subunits, single melting curves were interpreted as a general indicator 
of assembly of a single major specie and of stability of the complex, as the different 
subunits unfolded co-operatively. Conversely, double melting curves were interpreted as 
an indication of either multiple species and/or partial or poor complex stability, and the 
corresponding conditions were therefore discarded.  
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Figure 2.18: Melting curves. (A) Example of melting curve obtained for the double hexamer, 
referred to condition F8 of Fig. 4.15 and visualized as first derivative of the raw data. The Tm 
corresponds to the apex. (B) Example of a double-phase melting curve obtained for the single 
hexamer, referred to condition F6. The shape of the curve was considered a key parameter in the 
data analysis.   
The double hexamer (Figure 4.18, A) is stable in a wide range of pH (between 5.0 and 
8.5). Salt generally increases its stability, mostly in the pH range between 7.5 and 8.5. 
However, no buffer gave a positive shift of the melting temperature (ΔTm > +2°C) when 
compared to Buffer GF-N; the latter was therefore chosen as best option for 
crystallization trials and biochemical analysis. 
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The single hexamer is stable in a much narrower pH interval, specifically in the 
physiological range. Increased stability is observed between pH 7.0 and 7.5 for low-salt 
buffers, and between 6.5 and 7.0 for buffers containing 250 mM NaCl. For pH over 7.0, 
the presence of salt seems to trigger a multiphase behaviour. Again, the reference buffer 
was considered the best condition, as all the tested buffers which gave a positive ΔTm also 
showed a double-phase melting curve (indicated by dashed bars in Figure 4.18). Based on 
the screening of conditions similar to the reference buffer and that generated multiphase 
curves, we inferred that 5% glycerol present in Buffer GF-N has a beneficial effect on the 
overall stability of the complex. Further Thermofluor assays experiments will be carried 
out in the future in the presence of variable amounts of glycerol, to help stabilizing the 
protein.           
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Figure 2.19: Summary of Thermofluor results. Melting temperatures (Y axes) are reported for 
each condition (X axes), both for double (panel A) and single hexamer (panel B). The colour code 
is the same used in Fig. 4.15, except for Buffer GF-N, which was tested in two different wells that 
are here highlighted in red. A difference of 1°C in the two melting temperatures was detected. The 
Tm of the reference buffer is represented throughout the graph by a dotted line, to immediately 
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visualize a positive shift in the Tm of any other condition. Dashed bars indicate buffers with a 
double-phase curve. In these cases the software calculated the Tm corresponding to each apex, 
but only the highest value is reported here. 
4.2.2.2 Circular Dichroism (CD) analysis 
Proper folding is required for protein function. Therefore, recombinant proteins and 
protein domains for structural or biochemical studies have to be biophysically 
characterized in order to assess whether they are correctly folded. Far-UV Circular 
Dichroism (CD) can be used for this purpose, as it allows to estimate the content of 
secondary structure in purified recombinant proteins and to detect partial unfolding 
(Corrêa and Ramos, 2009; Greenfield, 2006). Thus, CD spectra of putative single and 
double MCM hexamers were recorded and analysed with the K2D software (Andrade et 
al., 1993) to evaluate the content of different elements of secondary structures; this was 
then compared to the expected content from secondary structure predictions based on the 
amino acid sequences (see Materials and Methods for details). Based on the expected 
structural arrangement, if the double hexamer is a dimer of the single hexamer, single and 
double hexamers are expected to contain the same percentage of secondary structural 
elements. If differences are observed, they may suggest a variation in the stoichiometry of 
the subunits and/or structural rearrangements induced by the dimer formation.  
A first series of experiments was performed with protein samples in Buffer GF-N, which 
contains 250 mM NaCl; we observed that the strong absorbance by the salt NaCl masked 
the protein signal in the 190-200 nm range; lowering the NaCl concentration in the buffer 
from 250 to 150 mM did not improve the situation. NaCl is required for the stability of 
these proteins, thus it cannot be completely removed from the buffer. For this reason, we 
decided to limit the CD spectral analysis to the 200-250 nm range (Figure 4.19).  
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Figure 2.20: CD spectra of single and double hexamer. Measurements were performed in 
Buffer GF-N with 150 mM and 250 mM NaCl, at a final protein concentration of 0.5 µM.  
Reconstruction of CD spectra of samples of double hexamer using K2D was not possible, 
suggesting an error in the estimation of the protein concentration in the samples. In 
contrast, CD spectra of samples of the single hexamer could be fitted by K2D, yielding a 
content of secondary structures that correlates very well with the expected values based 
on predictions. This analysis suggests that the proteins are folded properly, and have the 
expected stoichiometry (Table 4.4 and Figure 4.20).  
Table 2.11: Secondary structure analysis for the single hexamer. The percentages of α-helix, 
β-strand and random coil estimated by circular dichroism were compared with the values 
predicted with the PSIPRED algorithm (Jones, 1999) from the primary structures of the six 
subunits, assuming the canonical 1:1 ratio (see Paragraph 3.7.3.4 of Materials and Methods). 
The global error is estimated to be 8%. 
 
 α-helix β-strand 
Random 
coil 
Estimation by CD 20% 25% 55% 
Prediction from  
primary structures 
20% 22% 58% 
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Figure 2.21: Comparison between theoretical and experimental CD curves of the single-
hexamer. Far-UV CD spectrum of putative single hexamer (green trace) overlaid to the spectrum 
reconstructed by K2D (blue trace); purple bars represent the difference between the experimental 
and calculated spectra. See Materials and Methods for sample concentrations and buffer 
composition. 
4.2.2.3 Analysis of DNA binding by Fluorescence Polarization assay 
The polarization of light emitted by a fluorophore that is excited by polarized light is 
inversely proportional to the rate of its tumbling (i.e. molecular re-orientation). A 
fluorophore attached to a small ligand (e.g. a small DNA duplex) emits largely 
depolarized light, because the molecule tumbles rapidly in solution. However, if the 
ligand is bound to a larger molecule, the fluorophore rotation is slowed and the emitted 
light retains a high degree of polarization (Figure 4.21, A). The measured polarization 
directly correlates with the fraction of bound ligand in solution, providing an easy way to 
monitor protein-ligand interactions (LiCata and Wowor, 2008; Moerke, 2009). 
Fluorescence Polarization assays were performed on putative single and double hexamers 
with 3 different DNA substrates (single strand, double strand and fork, Figure 4.21, B) to 
check for DNA binding activity. Data were analysed to derive binding affinities and 
substrate preferences.    
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Figure 2.22: Fluorescence polarization assay. (A) Basic principles of FP (from Oda et al., 
1998). Small molecules (i.e. the ligand) tumble rapidly and therefore the emitted light is 
effectively depolarized; larger molecules (i.e. the protein-ligand complex) tumble more slowly 
and  polarization of emitted light is retained to a larger extent. (B) Schematic representation of 
the three DNA probes used in the assay: single strand (blue), double strand (red), fork (green). 
Fluorescein at 5’ end is indicated by a green star. For details about DNA sequences, refer to 
Paragraph 3.7.3.5 of Materials and Methods.  
Fluorescence polarization is highly sensitive to the presence of precipitated or aggregated 
material in solution, therefore protein samples have to be stable and soluble. As 
previously indicated by thermal shift analysis, Buffer GF-N proved to be a suitable buffer 
that can stabilise the complexes, and was used for all the DNA binding assays despite its 
relatively high salt concentration (250 mM NaCl), which may interfere with DNA 
binding.  
B 
A 
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The single hexamer was tested in the FP assay using a DNA concentration of 10 nM and 
increasing amounts of protein ranging from 0 to 10 µM. Due to the tendency of the 
double hexamer to precipitate above 10 µM (corresponding to  ̴ 5 mg/ml), this complex 
was tested with a lower amount of DNA (2.5 nM) in order to obtain a saturated binding 
curve. Values of Kd (apparent binding constant) and Bmax (polarization at saturation) were 
calculated by fitting the data with the 1:1 binding model, which considers the binding of a 
single ligand to a single receptor.   
 
Figure 2.23 Analysis of fluorescence polarization data obtained for the single hexamer. 
Values of polarization obtained for each substrate at different protein concentrations were fitted 
to both the 1:1 binding model (dotted line) and the Hill equation (continuous line) using 
GraphPad Prism 5. Left panels show the entire binding curves, while right panels show a 
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magnification of their initial part to highlight the sigmoidal shape. Data are reported as average 
of three independent measurements, together with the corresponding standard deviation (error 
bars are not visible when the value is very low).  
Table 2.12 Binding of single hexamer to different DNA probes. Values of polarization at 
saturation (Bmax (mP)), apparent binding constant (Kd (µM)), Hill Slope (h) and  coefficient of 
determination (R2) are reported for each probe, with the corresponding values of standard 
deviation. The Hill equation is compared with the 1:1 binding model. 
 
ssDNA dsDNA Fork 
Hill eq. 1:1 Hill eq. 1:1 Hill eq. 1:1 
Bmax (mP) 283.50±2.38 363.50±15.69  211.30±3.19  281.40±12.40  168.10±3.67  202.70±5.58 
Kd (µM) 0.71±0.01  0.83±0.15 1.12±0.03  1.51±0.25  0.93±0.04  1.14±0.13 
h 2.37±0.07 / 2.26±0.11 / 1.59±0.09 / 
R2 0.9991 0.9607 0.9973 0.9700 0.9961 0.9857 
 
As shown in Figure 4.22, FP values obtained for the single hexamer are not properly 
fitted by the 1:1 binding model, as data clearly deviate from an hyperbolic trend and 
display a sigmoidal shape, which may suggest a cooperative system. For this reason, data 
were also analysed using the Hill equation, which resulted in a better fit, as indicated by 
higher values of R2. Results obtained with both binding models are reported in Table 4.5. 
The analysis for the single hexamer output Kd values in the micromolar range and a mild 
preference for ssDNA, consistent with data reported in the literature (reviewed by 
Bochman and Schwacha, 2009) and with the biological role of this complex, which is 
expected to exert its unwinding activity by translocation on ssDNA (Fu et al., 2011).  
As predicted by the shape of the binding curves, the Hill coefficient is greater than 1 with 
all the three DNA probes. In general, when this parameter deviates from unity it may 
suggest the presence of multiple independent binding sites and/or binding cooperativity 
(Endrenyi et al., 1975; Goutelle et al., 2008). However, the complexity of our system 
makes these values more difficult to interpret. A serious concern of these experiments is 
the fact that the single hexamer preparation is likely to include multiple species (as 
indicated by the Native PAGE gel of Figure 4.14), which may have different affinities for 
DNA, as suggested by EMSA (Figure 4.23). Moreover, MALS analysis (see Paragraph 
4.2.2.4) also raise the possibility that the single hexamer is unstable and disassemble into 
smaller oligomers, which may re-associate in presence of DNA.  
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Figure 2.24: EMSA of single hexamer with ssDNA. Increasing protein concentrations are able 
to shift higher amounts of ssDNA; however, the presence of two different bands of shifted DNA 
(indicated by the green and red arrows) suggest the presence of two different species in the 
protein sample or to alternative stoichiometries of binding.  
In contrast, binding curves of the double hexamer do not show a sigmoidal shape 
(Figure 4.24). The Hill coefficients calculated in each assay (data not shown) confirm the 
absence of binding cooperativity and agree with the 1:1 binding model. Our data suggest 
that the double hexamer generally has lower affinity for DNA compared to the single 
hexamer (Table 4.6), which may be consistent with data in the literature showing that the 
double hexamer loaded on the chromatin can passively slide along the dsDNA (Evrin et 
al., 2009; Remus et al., 2009). However, the combination of the sensitivity limits of the 
technique and the inability of the protein to remain in solution at the required 
concentrations, did not allow to reach saturation of the binding curves, thereby preventing 
the extrapolation of meaningful parameters. Our in vitro study showed that the double 
hexamer also has a mild preference for ssDNA: although consistent with the general 
observed affinity of MCM complexes, there are numerous evidence pointing to the 
assembly of a MCM double hexamer onto dsDNA (Evrin et al., 2009; Gambus et al., 
2011; Remus et al., 2009; Sun et al., 2014). However, the binding of the double hexamer 
onto dsDNA in vivo is the result of a complex loading process, mediated by other factors, 
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and a proper mechanistic understanding of all steps involved would require additional 
studies. 
 
Figure 2.25 Analysis of fluorescence polarization data obtained for the double hexamer. 
Values of polarization obtained for each substrate at different protein concentrations were fitted 
to the 1:1 binding model (dotted line) using GraphPad Prism 5. Left panels show the entire 
binding curves, while right panels show a magnification of their initial part: in contrast to the 
single hexamer (Fig. 4.22) they do not show a sigmoidal shape. Data are reported as average of 
three independent measurements, together with the corresponding standard deviation (error bars 
are not visible when the value is very low). 
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Table 2.13 Binding of double hexamer to different DNA probes. Values of polarization at 
saturation (Bmax (mP)), apparent binding constant (Kd (µM)) and coefficient of determination  (R2) 
are reported for each probe, together with the corresponding standard deviation. 
 ssDNA dsDNA Fork 
Bmax (mP) 401.60±32.33 452.60±48.31  420.90±34.25  
Kd (µM) 4.71±0.95  10.28±1.98  7.77±1.28  
R2 0.9706 0.9846 0.9858 
 
4.2.2.4 SEC-MALS and SAXS analysis 
In order to obtain preliminary structural information on our putative single and double 
hexamer, we performed preliminary SAXS experiments in collaboration with the group of 
Dr. Rambo at the Diamond Light Source. SAXS is an experimental technique which 
allows to rapidly obtain a low resolution structural characterization of biological 
macromolecules in solution. SAXS is based on the scattering of X-ray photons by 
macromolecules: when a monochromatic wave hits an object, the electrons of its atoms 
become sources of secondary waves, which can be recorded and analysed to obtain 
information about the size and the shape of the molecule (Blanchet and Svergun, 2013; 
Boldon et al., 2015; Putnam et al., 2013). Moreover, since the sample doesn’t need to be 
crystallised, it can be analysed in a variety of conditions. 
As SAXS produces an averaged model of all the molecules in solution, monodispersity of 
the protein sample is a crucial prerequisite to obtain reliable data. Therefore, a quality 
control of the sample is strongly advised before performing a SAXS data collection. For 
this purpose, a series of SEC-MALS experiments was carried out on both single and 
double hexamer. In this technique, the sample is injected on a SEC column, which 
separate molecules of different size. Each fraction eluted from the column is immediately 
analysed by a MALS detector, that measures the light scattered at different angles. The 
amount of scattered light is directly related to the molar mass of the eluted protein (Sahin 
and Roberts, 2012). Thus, SEC-MALS provides useful information regarding the 
homogeneity of the sample. Due to time constraints, the analysis of the SEC-MALS and 
SAXS data is very preliminary. 
As shown by panel A of Figure 4.25, the double hexamer is characterised by mass  
heterogeneity; however the condition greatly improves when the original Buffer GF-N is 
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substituted with a new buffer containing phosphate and sucrose (see Paragraph 3.7.3.7 of 
Materials and Methods for the exact composition), which probably stabilises the complex 
by mimicking DNA. The single hexamer clearly shows the presence of two distinct 
species, with molecular mass of ~250 and 100 kDa respectively (Figure 4.25, B). This 
finding supports the hypothesis that this complex is probably less stable and disassemble 
into smaller oligomers, as previously suggested by the native PAGE and the Thermofluor 
assay.  
   
 
Figure 2.26: Mass distribution across the elution peak of double and single hexamer. (A) 
Values of molar mass (g/mol) over time (min) are reported for the double hexamer with Buffer 
GF-N (green curve) and the new buffer with phosphate and sucrose (magenta curve). (B)  The 
B 
A 
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same analysis performed with Buffer GF-N on the single hexamer suggest the presence of two 
different species. 
Due to the inhomogeneity of the single hexamer sample, SAXS measurements were 
performed only on the double hexamer. Also with the latter, we have been yet unable to 
obtain an ab-initio 3D reconstruction. As shown in Figure 4.26, the obtained experimental 
scattering curve was compared with theoretical curves of different single and double 
hexamer models obtained from the crystal structures of Mth, Sso, Pfu and TacMCM, and 
from the EM model of MCM2-7 of S. cerevisiae (as summarised in Table 3.6 of Materials 
and Methods). Different conformational states were reproduced: open and close single 
hexamer, planar and shifted double hexamer (the shifted models mimic the arrangement 
observed for the N-terminal domains of the yeast double hexamer (Sun et al., 2014)). 
Values of χ2 indicate the fitting of the theoretical curves to the experimental one (the 
smaller is this value, the better is the fitting). Higher similarity is in general registered 
with all the double hexamer models, strongly supporting the hypothesis that our 
recombinant human N-terminal domains really assemble into a double hexamer. 
However, this preliminary analysis doesn’t allow to make other assumptions on the 
general organization of the assembly, as no particular preference is detected between 
planar and shifted models. This could be probably ascribed to the fact that the six distinct 
human domains may assume an overall conformation which is partly different from the 
one of the archaeal complex. Surprisingly, the model which was expected to be more 
similar to the experimental data, the N-terminal domains extracted from the yeast double 
hexamer, did not fit as well as we expected. A possible explanation may be due to the 
difficulties in obtaining the exact magnification in electron microscopy experiments. 
However, it is possible that the conformation of the N-terminal domain alone may be 
somehow different, possibly with a reorientation of the additional N-terminal regions of 
the long subunits and/or the inferred reorientation of some subdomain A (Costa et al., 
2008; Fletcher et al., 2003; Jenkinson et al., 2009). 
In summary, although we have confirmed the presence of a double-hexameric complex, 
due to the complexity of the system, the non-homogeneity of the sample, and the time 
needed to optimize the buffer, we have been unable to obtain an ab-initio 3D 
reconstruction or to definitely confirm the exact architecture of the human double 
hexamer.  
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Figure 2.26: Fitting of experimental scattering curve with different MCM models. The 
scattering curve (grey) obtained for the double hexamer is here reported, by plotting the 
logarithm of the scattering intensity (Y axes) over the corresponding scattering vector q (X axes). 
Theoretical scattering curves of single (SH) and double hexamer (DH) in different conformations 
were generated with CRYSOL, from different crystallographic and EM models, and compared 
with the experimental data. For each model, values of radius of gyration (Rg) and goodness of the 
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fit (χ2) are reported. (A) MthMCM, (B) SsoMCM, (C) PfuMCM, (D) Yeast MCM2-7 and 
TacMCM. 
4.2.3 Crystallization trials 
Although the purity and homogeneity of the samples obtained so far were not ideal for 
crystallization, an initial screening of crystallization conditions for the single and double 
hexamers was performed using a number of commercial 96-well sparse matrixes (see 
Paragraph 3.7.4.1 of Materials and Methods). Two hits were found that gave small 
putative protein crystals of the double hexamer. These are hereafter named Condition 1 
(3mg/ml double hexamer in Buffer GF-N, 20°C, Wizard I+II H11: 100 mM imidazole pH 
8.0, 2.5 M NaCl, 200 mM Zn(OAc)2) and Condition 2 (4mg/ml double hexamer in Buffer 
GF-N, 20°C, Morpheus A5: 100 mM Sodium HEPES pH 7.5, 100 mM MOPS pH 7.5, 60 
mM MgCl2, 60 mM CaCl2, 30% PEG500MME, 30% PEG20000). Both conditions were 
further optimized in order to obtain larger crystals.  
Condition 1 was selected for a first optimization trial on a 24-well plate. Condition 2 was 
not tested as it contains a mixture of different buffers, precipitants and additives that is 
more difficult to reproduce in house. A screening was set up to test different 
concentrations of the major precipitant (sodium chloride, from 2.00 M to 2.75 M) and 
additive (zinc acetate, from 0.02 M to 0.30 M). 
In a second attempt, the small crystals obtained from both conditions were used for a 
microseeding experiment. Microseeding is a well-known technique consisting in the use 
of microcrystals as nucleation centres to grow larger crystals in new screening conditions. 
In this case, the same crystallization cocktail was used and tested with different dilutions 
of seeds (from 10
-3
 to 10
-7
). The in house reproduced crystallization cocktail was used for 
Condition 1, while the original buffer from the provider was used for Condition 2.  
Unfortunately, both attempts to reproduce these crystals failed. This may be probably 
ascribed to multiple reasons. Different preparations of protein were used, which can differ 
for the extent of contamination by proteolytic products, DNA and other protein 
contaminants as well as present slightly different stoichiometries. In case of Condition 1, 
the problem may be also related to the failure to exactly reproduce the crystallization 
cocktail. Moreover, the passage from the sitting drop to the hanging drop vapour 
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diffusion method and the scale up of the of the volume of the crystallization drops may 
introduce further variability.      
  
Figure 2.277: Double hexamer crystallization trials. (A) Needle-like crystals grown in 
condition H11 of Wizard I + II (100 mM Imidazole pH 8.0, 2.5M NaCl, 200 mM Zn(OAc)2). (B) 
Rod-shaped crystals (yellow arrows) grown in condition A5 of Morpheus (100 mM Sodium 
HEPES pH7.5, 100 mM MOPS pH 7.5, 60 mM MgCl2, 60 mM CaCl2, 30% PEG 500MME, 30% 
PEG 20000).   
 
4.3 Conclusions and future perspectives 
Although the MCM proteins are widely studied, unanswered questions remain, especially 
from the structural perspective. No high-resolution crystallographic structure is available 
for any eukaryotic MCM complex. Given this premise, this project aimed to obtain high 
quantities of pure recombinant human MCM proteins suitable for structural studies. Using 
the biochemical information available in the literature, we designed fragments of the six 
human MCM proteins corresponding to the AAA+ and the N-terminal domains. 
The AAA+ domains were cloned generating single constructs as well as polycistronic 
vectors suitable for the E. coli expression system. Their ability to produce soluble AAA+ 
domains has been tested under a range of different conditions, including different cell 
strains, media, temperature and induction methods. Several purification attempts were 
made: AAA+ domains have been (i) purified one by one or (ii) co-purified, or (iii) co-
expressed (also in presence of non-cleavable ATP analogues). All these approaches 
confirmed the high instability and/or the low solubility of these fragments. Similar results 
from studies on S. pombe MCM7/4/6 (Xu et al., 2013) as well as those by Hesketh et al. 
(2015) on human proteins, strongly suggest that the solubility of the AAA+ domain 
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strongly depends on the presence of the corresponding N-terminal domain, as well as the 
other subunits. However, other expression strategies, such as the use of an eukaryotic 
expression system (either insect or mammalian cells) may be tested in future to overcome 
the stability and solubility problems, although so far they have not produced sufficient 
quantities for crystallographic studies (Kang et al., 2012; You et al., 2013). 
Hesketh et al. (2015) recently managed to express and purify a recombinant human 
MCM2-7 helicase from E. coli, which exhibits unwinding activity without any 
requirement of post-translational modifications or accessory proteins (like, for instance, 
GINS and Cdc45). Unfortunately, the amounts obtained are still short for a 
crystallographic analysis. In parallel effort, we successfully expressed high levels of the 
N-terminal domains of the human homologue of this enzyme in bacteria, and we started 
to develop an efficient method for purification. The co-purification of the different 
domains, by mixing the pellet coming from different cultures, led to the assembly of a 
single hexamer, capable of binding DNA, with a preference for single-stranded substrates. 
Our preliminary biochemical characterization, which is consistent with data reported in 
the literature for other species, as well as circular dichroism experiments, strongly 
indicate that our recombinant proteins are properly folded. On the other hand, native gels 
and SEC-MALS experiments suggest that the single hexamer is not very stable and that 
we may be in the presence of multiple species, and a variety of stoichiometries.  
We also detected another assembly compatible with a MCM double hexamer. 
Biochemical and biophysical analyses suggest that the single and double hexamers may 
have different functional properties. The high yield obtained with our purification 
protocol ( ̴ 2.5-3 mg of each oligomer from 1 L of culture) is a promising starting point 
for optimizing the purification protocols so as to be able to undertake crystallization 
screenings and other structural studies.  
Further studies are indeed required to elucidate possible differences between the two 
oligomers. For this purpose, we recently started to investigate their structural properties 
by Small Angle X-ray Scattering (SAXS). This analysis needs to be repeated with more 
homogeneous samples, as well as in the presence of a variety of nucleic acid substrates. 
Moreover, we also generated a new set of protein constructs lacking the predicted random 
coil regions of the N-terminal domains, in order to elucidate their role in the MCM ring 
assembly and function.  
100 
 
  
101 
 
APPENDIX 1. SEQUENCE ALIGMENT OF MCM PROTEINS 
Figure A.1: Sequence alignment of MCM homologues. 
Protein sequences of the MCM2 homologue from Methanopyrus kandleri (metka), the MCM 
homologues from Methanothermobacter thermautotrophicus (metth), Archaeoglobus fulgidus 
(arcfu), Thermoplasma acidophilum (theac), Sulfolobus solfataricus (sulso), Aeropyrum pernix 
(aerpe), and the MCM2-7 homologues from Saccharomyces cerevisiae (yeast), 
Schizosaccharomyces pombe (schpo), Xenopus laevis (xenla), Homo sapiens (human), Drosophila 
melanogaster (drome), were aligned using the program ClustalW and manually adjusted to 
obtain a structure-based alignment, using the atomic structure of the N-terminal domain of 
MthMCM (PDB entry 1LTL) and the AAA+ domain of the MkaMCM as reference. 
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APPENDIX 2. BUFFERS, MEDIA AND SOLUTIONS 
Media 
All media were autoclaved and stored at room temperature. Antibiotics were added at the 
specific final concentration prior to use. 
LB medium: LB powder was dissolved in deionised water (20 g per litre).  
TB medium: TB powder was dissolved in deionised water (47 g per litre) and added with 
glycerol (8 ml per litre). 
LB 5052: LB powder was dissolved in deionised water (20 g per litre) and 1 ml of 1 M 
MgSO4, 20 ml of 50x 5052 and 50 ml of 20x NPS were added per litre of medium. 
LB Agar and agar plates: 5.25 g of LB agar powder were added to 150 ml deionised 
water and autoclaved. The medium was allowed to cool to 50ºC before adding antibiotics 
to the specified final concentrations. 20 ml of medium were poured into 85 mm petri 
dishes. The medium was left to harden for one hour and the agar plates were stored at 4ºC 
for ≤ 1 month. 
Antibiotic stock solutions (1000x) 
Ampicillin: 0.5 g of ampicillin sodium salt were dissolved in 10 ml of deionised water, 
filter sterilized and stored at -20°C. Ampicillin was added to growth medium at a final 
concentration of 50 µg/ml.  
Chloramphenicol:  0.34 g of chloramphenicol were dissolved in 10 ml of ethanol, filter 
sterilized and stored at -20°C. Chloramphenicol was added to growth medium at a final 
concentration of 34 µg/ml. 
Kanamycin: 0.25 g of kanamycin monosulphate were dissolved in 10 ml of deionised 
water, filter sterilized and stored at -20°C. Kanamycin was added to growth medium at a 
final concentration of 25 µg/ml. 
Buffers for protein purification 
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All buffers used for purifications were filtered through 0.45µm membrane filter, degassed 
and stored at 4°C. Lysozyme, DNAse and β-mercaptoethanol (βME) were added prior to 
use, where required. 
Lysis buffers 
Buffer L1: 20 mM Tris pH 7.9 (at 4°C), 500 mM NaCl, 10% Glycerol, 10 mM Imidazole, 
1 mM AEBSF, 1 mg/ml Lysozyme, 0.1 mg/ml DNAse, 10 mM MgSO4. 
Buffer L2: 20 mM Tris pH 7.4 (at 4°C), 200 mM NaCl, 1 mM AEBSF, 1 mg/ml 
Lysozyme, 0.1 mg/ml DNAse, 10 mM MgSO4. 
Buffer L3: 20 mM Tris pH 7.9 (at 4°C), 200 mM NaCl, 10% Glycerol, 10 mM Imidazole, 
1 mM AEBSF, 1 mg/ml Lysozyme, 0.1 mg/ml DNAse, 10 mM MgSO4, 1 mM ADP, 3 
mM AlCl3, 15 mM NaF. 
Affinity chromatography 
Buffer A: 20 mM Tris pH 7.9 (at 4°C), 500 mM NaCl, 10% Glycerol, 2 mM βME. 
Buffer B: 20 mM Tris pH 7.4 (at 4°C), 200 mM NaCl, 2 mM βME. 
Buffer C: 20 mM Tris pH 7.9 (at 4°C), 200 mM NaCl, 10% Glycerol, 1 mM ADP, 3 mM 
AlCl3, 15 mM NaF, 2 mM βME. 
Ion exchange chromatography 
Buffer IEx: 20 mM Hepes pH 7.0, 2 mM βME. 
Size exclusion chromatography 
Buffer GF-A: 20 mM Hepes pH 7.4, 150 mM NaCl, 5% Glycerol, 2 mM βME. 
Buffer GF-N: 30 mM Tris pH 7.9 (at 4°C), 250 mM NaCl, 5% Glycerol, 2 mM βME. 
Buffers for SDS-PAGE 
SDS Sample Buffer (4x): 200 mM Tris-HCl, pH 6.8, 40% (v/v) glycerol, 8% (w/v) SDS, 
400 mM dithiothreitol (DTT), 0.08% (w/v) bromophenol blue. 
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Tris Glycine SDS Separating gel solution: 0.39 M Tris-HCl, pH 8.8, 0.1% lauryl sulphate 
(SDS), 12% Acrylamide/Bis, 0.1% ammonium persulphate (APS) and 0.04% ,N,N’,N’-
tetramethylethylenediamine (TEMED). 
Tris Glycine SDS Stacking gel solution: 0.13 M Tris-HCl, pH 6.8, 0.1% SDS, 5% 
Acrylamide/Bis, 0.0005% APS and 0.001% TEMED. 
Tris-Glycine-SDS Buffer: 25 mM Tris, pH 8.6, 192 mM glycine, 0.1% SDS.  
Buffers for Native PAGE 
Tris Glycine Separating gel solution: 0.39 M Tris-HCl, pH 8.8, 6% Acrylamide/Bis, 0.1% 
APS and 0.04% , TEMED. 
Sample Buffer (4x): 200 mM Tris-HCl, pH 6.8, 40% (v/v) glycerol, 400 mM dithiothreitol 
(DTT), 0.08% (w/v) bromophenol blue. 
Tris-Glycine Buffer: 25 mM Tris, pH 8.6, 192 mM glycine. 
Agarose gel buffers 
TBE: 89 mM Tris Base, 89 mM Boric Acid, 2 mM EDTA pH 8.0. 
DNA Sample Buffer (6x): 30% glycerol, 0.25% bromophenol blue. 
Others 
DNA oligonucleotides: primers for RF cloning and oligos used for DNA binding 
experiments were supplied as desalted, lyophilised powders (Sigma-Genosys, UK). DNA 
powder was resuspended in deionised water to a final concentration of 100 μΜ. Α further 
dilutions were made to produce working stocks. Stock solutions were stored at -20ºC. 
Annealing Buffer: 10 mM Tris, pH 7.5, 50 mM NaCl, 1 mM EDTA. 
IPTG: IPTG powder was dissolved in deionised water to a final concentration of 1 M. 
The solution was filter sterilised, wrapped in foil and stored at -20ºC. 
AEBSF: AEBSF powder was dissolved in water to a final concentration of 200 mM. The 
stock was stored at -20ºC. 
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MgSO4 (1M): 2.46 g of magnesium sulfate heptahydrate were dissolved in 10 ml of 
deionised water, filter sterilized and stored at room temperature. 
NPS (20x): 0.5 M (NH4)2SO4, 1 M KH2PO4, 1 M Na2HPO4. 
5252 (50x): 25% (w/v) glycerol, 2.5% (w/v) glucose, 10% (w/v) α-lactose. 
SAXS experimental buffer: 20 mM Hepes pH 7.5, 25 mM KH2PO4, 50 mM NaCl, 100 mM 
KCl, 0.5% (w/v) sucrose. 
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APPENDIX 3. EXPERIMENTAL PROTOCOLS 
Expression and purification of Ulp1 
The sequence of the SUMO-protease (Ulp1, from S. cerevisiae), cloned into pET-28b 
plasmid, is a kind gift of Dr. Christopher Lima.  
The protein is expressed in E. coli BL21 (DE3) strain. Cells are grown at 37°C to 
OD600=2 and induced by addition of IPTG to a final concentration of 0.75 mM. The 
culture is incubated for 4 hours at 30°C and cells are subsequently harvested by 
centrifugation (7000 g for 30 min).  
Cell pellet is resuspended in Buffer 1 (50 mM Tris, pH 8.0, 300 mM NaCl, 25 mM 
imidazole, 10% glycerol, 0.2% (v/v) IGEPAL, 1 mM βME, 1 mM PMSF) and cells are 
disrupted by sonication. Cell debris is removed by centrifugation (25000 g for 45 min) 
and the supernatant is applied to Ni-NTA resin, equilibrated with Buffer 1. To elute 6His-
Ulp1 from the Ni-NTA resin, a step gradient with Buffer 2 (50 mM Tris, pH 8.0, 300 mM 
NaCl, 500 mM imidazole, 10% glycerol, 1 mM βME, 1 mM PMSF) is applied to the 
chromatography column. Peak fractions containing 6His-Ulp1 are dialyzed overnight at 
4°C against Buffer 3 (25 mM Tris, pH 8.0, 250 mM NaCl, 1 mM DTT, 20% glycerol). 
The protein is eventually concentrated with a centrifugal filter (MWCO: 3 kDa), 
aliquoted and stored at -80°C.  
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